East Tennessee State University

Digital Commons @ East
Tennessee State University
Electronic Theses and Dissertations

Student Works

5-2016

Regulation of Acute and Chronic Immune
Responses by β-Arrestin2
Hui Yan
East Tennessee State Universtiy

Follow this and additional works at: https://dc.etsu.edu/etd
Part of the Biochemistry, Biophysics, and Structural Biology Commons
Recommended Citation
Yan, Hui, "Regulation of Acute and Chronic Immune Responses by β-Arrestin2" (2016). Electronic Theses and Dissertations. Paper
3049. https://dc.etsu.edu/etd/3049

This Dissertation - Open Access is brought to you for free and open access by the Student Works at Digital Commons @ East Tennessee State
University. It has been accepted for inclusion in Electronic Theses and Dissertations by an authorized administrator of Digital Commons @ East
Tennessee State University. For more information, please contact digilib@etsu.edu.

Regulation of Acute and Chronic Immune Responses by β-Arrestin2
_____________________
A dissertation
presented to
the faculty of the Department of Biomedical Science
East Tennessee State University

In partial fulfillment
of the requirements for the degree
Doctor of Philosophy in Biomedical Sciences
_____________________
by
Hui Yan
May 2016
_____________________
Dr. Deling Yin, Chair
Dr. Alok Agrawal
Dr. Balvin H. Chua
Dr. Dennis M. Defoe
Dr. Donald B. Hoover
Keywords: β-arrestin2; Sepsis; Stress; Ischemia/reperfusion; TLR-9; MiR-155

ABSTRACT
Regulation of Acute and Chronic Immune Responses by β-Arrestin2
by
Hui Yan
β-arrestin2, previously recognized as a facilitator for G-protein associated 7 TMR
desensitization/ internalization, has now been appreciated as an independent signal transducer
that regulates multiple cellular responses including inflammation. Cecal ligation and puncture
procedure (CLP) induced septic shock is an acute inflammatory response characterized by
uncontrolled systemic inflammation. Myocardial ischemia/reperfusion is a chronic sterilize
inflammation that requires the reaction of macrophages, fibroblasts and cardiac stem cells for
regeneration and remodeling of the infarcted myocardium. Restrained chronic stress is an
immune suppression model in which the inactivation of macrophages may be involved. Here we
showed β-arrestin2 overexpression inhibited CLP-induced heart dysfunction in septic shock,
stabilized the cardiovascular system, and eventually promoted survival. Inhibition of the
activation of p38 that downstream of the IL-6 pathway may be a key regulatory target for βarrestin2. To rescue cardiomyocytes from ischemia and reperfusion injury, Sca-1+ CSC from
Wide-type or β-arrestin2 Knockout mice were delivered to the risked area before reperfusion; βarrestin2 was shown to be a required factor and a promoter for the differentiation of the cardiac
stem cells. A β-arrestin2/miR-155/GSK3β pathway was identified in this study. TLR-9 is an
important part of the innate immune system which has been shown to be regulated by β-arrestin2
in various inflammatory models. Here we found, the immune suppression induced by restrained
stress is mediated by Toll-like receptor 9 (TLR-9). TLR-9 facilitated the elevation of IL-1β, IL10 and IL-17 levels in serum and decrease of the levels of plasma IFN-γ. Furthermore,
macrophage apoptosis was alleviated in TLR-9 deficiency mice. In summary, β-arrestin2 and
2

associated proteins like TLR-9 are important regulators of the immune response in a variety of
disease conditions. Therapeutic strategies should be generated to balance the inflammation and
anti-inflammation response by modulating β-arrestin2 expression and functions.
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CHAPTER 1
INTRODUCTION
The Arrestin Family
History
GPCR Rhodopsin, also called visual purple, was discovered in the late nineteenth century
due to its unique color changing property in the pigment of retina 17. In 1980s, the architecture
similarity between visual sensory protein rhodopsin and some widely distributed seven transmembrane receptors lead to the discovery of the largest family of cell surface receptors called Gprotein-coupled receptors (GPCRs). The binding of extracellular ligand to its GPCRs induces
conformational changes of the receptors themselves as well as the downstream phosphorylation
of G proteins (guanylate nucleotide-binding protein).

Arrestins Arrestins were discovered in the study of desensitization of rhodopsin and beta 2
adrenergic receptors 48. Arrestin 1 is the fist member of arrestin family that is found can facilitate
dampening of signaling transduction pathway mediated through rhodopsin in retina. β-arrestin 1
and 2, also called arrestin2 and 3 are the homologs of arrestin1 that are identified by gene clone
technology associate with β-2 adrenergic receptors in early studies.

Functions of β-arrestins
G-protein Related Functions Arrestins can compete with G protein in binding with
GPCRs and terminate the signaling transduction through G proteins. Therefore, GPCRs are
desensitized to agonist by arrestins, which is triggered by the conformational change and
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phosphorylation of receptors. Arrestins are also involved in the internalization/endocytosis of
GPCRs, along with trafficking proteins such as clathrin and AP2 33,47.

G-protein Independent Functions Recently, more and more G protein independent but
arrestins required GPCRs signaling pathway were reported. GPCRs were preferably called seven
trans-membrane receptors (7TMRs), and arrestins had been recognized as direct signaling
transducers rather than adaptors and regulators at these circumstances 105. In this study, we focus
on the G protein independent functions of arrestins.

Function of β-arrestin2 in Inflammation
The knowledge of β-arrestin2 as a negative regulator for inflammation is mainly
confined to cells of immune systems 29,91,3. Recently, it has been shown that β-arrestin2 regulates
innate immune system by targeting Toll-like receptor-interleukin 1 receptor (TLR-IL-1R)
especially Toll-like receptor 4 (TLR4) signaling 105,53. Interestingly, increased β-arrestin2
expression in monocyte is associated with less activated immune system during myocardial
infarction 106. However, the role of β-arrestin2 in cardiovascular system during sepsis remains to
be elucidated.

Function of β-arrestin2 in Heart Injury
β-arrestin2 mediates positive inotropic change in heart through enhanced Ca2+/calmodulin
kinase II activation, myosin light chain phosphorylation and Ca2+ responsiveness in
myofilament 82,62,92. β-arrestin2 stimulation is cardio protective in acute cardiac injury, heart
ischemia/reperfusion, chronic hypertension and post injury ventricular remolding 69,45,38. The
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reported anti-apoptotic mechanism of β-arrestin2 includes inhibition of BAD phosphorylation
and p38 activation 48,112. Furthermore, β-arrestin2 promotes smooth muscle cell (SMC)
proliferation in vitro 106. Therefore, it would be interesting to explore the effect of β-arrestin2 on
hemodynamic profile during sepsis.

MiR-155
MiR-155 and Inflammation
Micro RNA are short (20-24 nt in length) non-coding single strand RNA that can regulate
protein gene expression at post-transcriptional level in mammals. In immune system, it has been
shown MiR-155 played an important role in T cell differentiating into regulatory T cell and
different subsets of helper T cells 86,97,101. In addition, miR-155 is required for CD8+ T cell
proliferation and effective responses to infections 35. Cardiomyocyte ischemia and reperfusion is
a form of sterilized inflammation, so immune regulation by miR-155 may affect disease
progress.

MicroRNA and Cardiomyocyte Differentiation
Cardiomyocyte differentiation, survival and regeneration has been shown to be regulated
by a group of microRNAs. For example, MiR-155 promotes cardiac survival. MiR-1 and miR499 were able to promote cardiomyocyte differentiate from cardiac progenitors. Fibroblasts can
be differentiated into cell with similar characteristic of cardiomyocyte with the help of miR-1,
miR133, miR208 and miR409. There are also several microRNAs could enhance cardiac
proliferation and re-programing. Emerging evidence suggests microRNAs are great targets for
regulation of cardiomyocyte differentiation following ischemia reperfusion 96. As the protective
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role of β-arrestin2 in cardiac ischemia/reperfusion has been indicated above, the association
between β-arrestin2 and miR155 should be determined in the process of cardiomyocyte
differentiation from cardiac stem cells followed by ischemia/ reperfusion injury.

Beta-arrestin2 and Toll-like Receptors
Toll-like Receptors
Toll like receptors are part of the innate immune system that enabled host to clear
infections without the involvement of adaptive immune system. Thirteen TLRs are discovered in
the TLR family, most of which recognize specific pathogen structures and deliver signals
through MyD88. TLR9 is activated by oligodeoxynucleotides with unmethylated CpG motifs.
TLR9 is located within the cells, in ER before stimulation 50. TLR9 is required for apoptosis in
various cell types including microglia in CNS 36. Our results also showed decreased
inflammatory response in TLR9 knockout mice in septic model 41. The role of TLR9 in chronic
stress induced macrophage apoptosis is still undefined.

Beta-arrestin2 Regulates Toll-like Receptors 9 in Inflammation
Previous studies have shown β-arrestin2 could inhibit signaling transduction though Tolllike receptor-Interleukin 1 receptor by regulating TRAF6 105. β-arrestin2 could also regulate
Toll-like receptor 4 by GSK 3β 53. All the results suggest β-arrestin2 may indirectly regulate
other members of TLR family including TLR9. As the potential regulatory target for β-arrestin2,
the anti-inflammatory effect of decreased TLR9 expression was tested in this study.
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Specific Aims

1. This study aims to investigate The role of β-arrestin2 in sepsis induced heart dysfunction and
survival. To explore whether the expression of β-arrestin2 could affect the signaling
transduction of the interlukin-6 pathways in septic hearts.
§Some of the findings in Chapter 2 are reproduced from our submitted paper which is in
revision process, reference# 110. Additional unpublished results are reported in Chapter 2
2. This study aims to investigate the contribution of miR155 in β-arrestin2 mediated cardiac
stem cell differentiation induced by 5aza and the mechanism of action. Whether the
theories generated from of in vitro studies could apply to the treatment of
myocardiac infarction in mice.
§We published the findings in Reference# 122. The published findings are reproduced in
Chapter 3
3. This study aims to investigate the effect of TLR-9 in chronic stress induced inflammation in
mice. Whether the TLR-9 is required in the progression of chronic inflammation. The
molecular mechanism underlying the response of inflammatory factors and
macrophages.
§We published the findings in Reference# 108. The published findings are reproduced in
Chapter 4

20

CHAPTER 2
β-arrestin2 Attenuates Cardiac Dysfunction In Polymicrobial Sepsis Through gp130 And p38

Hui Yan a, Hui Li a, James Denney a, Christopher R. Daniels b, Krishna Singh b, Balvin H.L.
Chua c, Ronald C. Hamdy c, Charles Stuart a, Yi Caudle a, Gene LeSage a, Deling Yin a,*

a

Departments of Internal Medicine, b Biomedical Sciences, and c Cecile Cox Quillen Laboratory

of Geriatrics, College of Medicine, East Tennessee State University, Johnson City, Johnson City,
TN 37614, USA

Key words: β-arrestin2; Sepsis; Cardiac function; Gp130; P38

Running title: Cardioprotective effect of β-arrestin2 on sepsis

Correspondence author:
Deling Yin, M.D., Ph.D., Professor, Department of Internal Medicine, College of Medicine, East
Tennessee State University, Johnson City, TN, USA 37614, Phone: 423 439 8826, E-mail:
yin@etsu.edu

Reference: Some of the results are in revision in Biochemistry and Biophysics Reports.
Additional unrevised results are reported in this chapter 2 (Manuscript in preparation)
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Abstract
Sepsis is an exaggerated systemic inflammatory response to persistent bacteria
infection with high morbidity and mortality rate clinically. β-arrestin2, a principal regulator, and
scaffolds of various signaling, modulates cell survival and cell death in different systems.
However, the effect of β-arrestin2 on sepsis-induced cardiac dysfunction is not yet known. Here,
we show that β-arrestin2 overexpression significantly enhances animal survival following cecal
ligation and puncture (CLP)-induced sepsis. Importantly, overexpression of β-arrestin2 in mice
prevents CLP-induced cardiac dysfunction. Also, β-arrestin2 overexpression dramatically
attenuates CLP-induced myocardial gp130 and p38 mitogen-activated protein kinase (MAPK)
phosphorylation levels following CLP. Therefore, β-arrestin 2 prevents CLP-induced cardiac
dysfunction through gp130 and p38. These results suggest that modulation of β-arrestin2 might
provide a novel therapeutic approach to prevent cardiac dysfunction in patients with sepsis.
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Introduction

Sepsis, a significant clinical problem, is one of the leading causes of death in intensive
care units throughout the world (1). Sepsis is the No.1 cause of morbidity and mortality in
intensive care units (ICUs), and about 60% of patients admitted to the ICU have cardiac
dysfunction (2-4). When accompanied by heart dysfunction, survival for sepsis is only 30%
(1,2). An average of 7.5 million incidences of severe sepsis are recorded in the United States
yearly, and the number is rising at a steady rate. The prognosis of sepsis is different from person
to person. However, the mortality rate is nearly 40 percent in an advanced aged patient under
severe sepsis in spite of aggressive treatment (1,2). Cardiac dysfunction plays a critical role in
the high morbidity and mortality of this condition (2-4). Therefore, it is urgent to elucidate the
mechanisms by which sepsis modulates cardiac dysfunction and generate more efficient ways to
improve the prognosis.
β-arrestin2, a universally expressed member of arrestin family in many tissues with
especially high expression in nervous and cardiovascular tissues (5-7), is an essential negative
regulator of the G-protein-coupled receptor (GPCR) signaling (5,7-9). β-arrestin2 not only
facilitates G-protein associated 7 TMR desensitization/internalization but also mediates
intracellular signal transduction independently (5,9). In addition to these established functions,
β-arrestin2 increasingly represents an active line of investigation where β-arrestin2 binds with
various target molecules and thus modulates a broad range of biological processes (10-12).
Recent evidence has shown that β-arrestin2 is functionally involved in the regulation of immune
responses by modulating various signaling pathways (11,12). β-arrestin2 stimulation protects
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against acute cardiac injury (13,14). However, the effect of β-arrestin2 on cardiac function
during sepsis is not yet known.
The affinity between β-arrestin2 and mitogen-activated protein kinases (MAPKs) exhibited
in numerous cases of GPCR signaling (15-18). We and others recently reported that β-arrestin2
scaffolds MAPK components such as the MAP kinases extracellular-signal regulated kinase
(ERK) and c-Jun-N-terminal kinase (JNK), leading to phosphorylation, activation and
accumulation of MAPKs in defined cellular compartments (15,18). To examine the mechanisms
by which β-arrestin2 modulates cardiac functions, we focus on investigation of β-arrestin2 to
regulate glycoprotein 130 (gp130) and p38 MAPK signaling during sepsis.
Signal transducer and activator of transcription 3 (STAT3), the effector of IL-6/IL6R/gp130/JAK2/STAT3 pathway, receives signals from tyrosine kinase JAK2 via site 705
phosphorylation, translocates to the nucleus, and then regulates transcription of various survival
genes (e.g. BCL-xL) (34). Recently, STAT3 phosphorylation on Ser-727 is shown to help
improve the performance of electrotransfer chain in the mitochondria, block the mitochondrial
pole and protect cells from reactive oxygen species (ROS) (32). Importantly, tyrosine and serine
phosphorylation are both required for a maximized anti-apoptotic effect of STAT3 (33).
Although STAT3 has been reported to mediate the negative inotropic effect of IL-6 in isolated
myocytes by iNOS expression (35), for now, the overall effect of STAT3 in sepsis is undefined.
In the present study, we demonstrated that overexpression of β-arrestin2 enhances survival
and attenuates cardiac dysfunction in septic mice. Additionally, β-arrestin2 overexpression
prevents elevated levels of myocardial gp130 and p38 MAPK phosphorylation in polymicrobial
sepsis.
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Materials and Methods
Experimental Animals
Wild-type (WT) C57BL/6J mice were ordered from Jackson Laboratory (Bar Harbor, ME).
Arrb2 knockout (KO) mice on a C57BL/6 background were kindly provided by Dr. Robert
Lefkowitz (Duke University) and bred at East Tennessee State University (ETSU) (18). βarrestin2 over-expression (TG) mice were generated as previously described (19). Briefly, fulllength human β-arrestin2 cDNA from brain cDNA/λphage library was cloned into pcDNA3
(BamHI-EcoRI) with HA tag (HindIII-BamHI) under the control of a human cytomegalovirus
(CMV) promoter. Then the DNA constructions were injected into fertilized mice eggs with the
C57BL/6J background. The integration of variable copies of a transgene into the genomes of
founder mice and their offspring was verified. Real-time PCR analysis was used to check the
mRNA expression of the transgene. The genomic DNA primers used to identify transgenic mice
were β-arrestin2, sense 5’-CAGCCAGGACCAGAGGACA-3’, antisense 5’TGATAAGCCGCACAGAGTT-3’. There is no difference between physical appearance,
activity, productivity and life span in WT, β-arrestin2 KO, and β-arrestin2 TG mice. All mice
were maintained in the Division of Laboratory Animal Resources at ETSU, a facility accredited
by the Association for the Assessment and Accreditation of Laboratory Animal Care
(AAALAC). All animal studies were approved by the ETSU Committee on Animal Care.

Cecal Ligation and Puncture (CLP) Polymicrobial Sepsis
CLP was performed to induce sepsis in mice as described in our previous studies (20).
Briefly, mice were initially anesthetized by 5.0% isoflurane inhalation in 100% O2 in a closed
chamber and then maintained by 3% isoflurane inhalation during surgery. A small incision was
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made in the anterior abdomen, and the cecum was ligated 1 cm proximal to the terminal of
cecum with a size 2-0 sutures. The cecal puncture was done with a 20-gauge needle and the
content was extruded from two holes. The abdomen was then closed layer by layer. Mice without
ligation and puncture were served as control. Immediately following CLP or sham surgery,
40ml/kg pre-warmed saline was administrated by intraperitoneal injection.

Cardiac Functional Analysis (P-V loop)
Cardiac function was detected by use of the SPR-839 instrument (Millar Instruments,
Houston, TX, USA) as described previously by us (21). Briefly, a microtip pressure–volume
catheter (SPR-839; Millar Instruments, Houston, TX, USA) was inserted through a 25-gauge
apical stab into the LV to measure the steady-state cardiac function. At the completion of the
study, 10 µL of hypertonic saline (15%) was injected into the right atrium to calibrate Vp, the
parallel volume. The signals were continuously recorded at a sampling rate of 1000 s−1 using an
ARIA pressure–volume conductance system (Millar Instruments) coupled to a Powerlab/4SP
A/D converter (AD Instruments, Mountain View, CA, USA). All pressure–volume loop data
were analyzed with a cardiac pressure–volume analysis program (PVAN3.4; Millar Instruments).
At the end of the functional analysis, the hearts were removed and perfused for 2 min as
Langendorff preparations to remove the remaining blood before Western blot analysis.

Western Blot Analysis
Western blot analysis was performed according to established protocols (18, 22). Briefly,
Briefly, proteins extracted from heart tissue lysis were loaded to 10-15% SDS-PAGE then
transferred to a nitrocellulose membrane (Bio-Rad). The blocking solution was composed of 3%
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BSA dissolved in 1xTBS; blocking the membrane for 1 hour at room temperature. Incubated the
membrane for 2 hours at room temperature in primary antibody and 1hour in secondary
antibody, both in 1.5% BSA dissolved in 1xTBS. The signals were detected with the ECL system
(Amersham Biosciences). The signals were quantified by scanning densitometry and computerassisted image analysis. Pan p38, phospho-p38, pan ERK, phospho-ERK, pan JNK, phosphoJNK, pan STAT3, and phospho-STAT3 antibodies were from Cell Signaling Technology
(Beverly, MA). Pan gp130, phospho-gp130, and GAPDH antibodies were obtained from Santa
Cruz Biotechnology (Santa Cruz, CA).

Enzyme-linked Immunosorbent Assay (ELISA) for Cytokines
Blood collected from sham and CLP mice was allowed to clot for 2 hours at room
temperature and centrifuged for 20min at 2000×g. The level of IL-6, IL-1β, and TNFα in the
serum were quantified using Quantikine Mouse ELISA kits (R&D Systems, Minneapolis, MN).

Echocardiography
Transthoracic two-dimensional M-mode echocardiography was performed by a Toshiba
Aplio 80 imaging system as described (18, 9). Left ventricular end systolic volume (LVESV) and
the LV end diastolic volume (LVEDV) were calculated from left ventricular diameters measured
from M-mode tracings (10). Before and 6h after CLP, mice were kept warm using a heating pad
and maintained on 1% isoflurane anesthesia during echocardiography.

TUNEL Assay
Middle one third of heart was collected 6 h after CLP and fixed in 10% buffered
formalin. Paraffin embedded heart section was prepared. Cardiac myocyte apoptosis was
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examined by the TUNEL assay (Roche Diagnostic, Indianpolis, IN), according to the
manufacturer’s instructions. For each group, three slides were evaluated for the percentage of
cells that were apoptotic. Four fields of each slide were randomly examined using a defined
rectangular field area with a magnification of 40×.

Statistical Analysis
Comparisons of data from multiple groups were carried out using one-way analysis of
variance and Newman-Keuls multiple comparison tests. Means were compared by Student's ttest between two groups. All data were expressed as mean ± SEM. The Kaplan-Meier method
was used to generate the survival curves, and the significance of differences was ascertained
using the Log-rank (Mantel-Cox) test. P < 0.05 was considered statistically significant.
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Results
Overexpression of β-arrestin2 in Mice Enhances Animal Survival following CLP
First, we investigated the effect of the multifunctional protein β-arrestin2 (5,18) on animal
survival after sepsis. WT, β-arrestin2 TG, and β-arrestin2 KO mice were subjected to CLP, and
mortality was monitored for 120 h. As shown in Fig. 2.1, mortality occurred with highest
frequency 18-24 h after sepsis.

Figure 2.1. β-arrestin2 TG mice are less susceptible to CLP-induced polymicrobial sepsis.
WT, β-arrestin2 KO and β-arrestin2 TG mice (n = 15 per group) were subjected to CLP and
monitored up to 120 h. Survival Curves are compared by Log-rank (Mantel-Cox) test. *P < 0.05.

The survival rate 24 h after CLP was 40% for WT mice, 80% for β-arrestin2 TG mice, and
13.3% for β-arrestin2 KO mice. At the end of the observation period, the survival rates were
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20% in WT, 53.3% in TG, and 6.7% in β-arrestin2 KO group. There were no deaths in sham
control mice (data not shown). These results support that β-arrestin2 contributes to animal
survival following CLP.

β-arrestin2 Overexpression Attenuates Sepsis-induced Cardiac Dysfunction
Overexpression of β-arrestin2 Diminishes Sepsis-reduced Cardiac Output and Stroke
Volume. Very recently, it has been shown that sepsis induces cardiac dysfunction (23). However,
it is not known whether β-arrestin2 plays a role in sepsis-induced cardiac dysfunction. To
evaluate the effect of β-arrestin2 on cardiac function following sepsis, we collected
hemodynamics parameters by pressure-volume loop measurement 6 h after sepsis in WT, βarrestin2 KO, and β-arrestin2 TG mice. As shown in Fig. 2.2A, 67 % of cardiac output was
preserved in β-arrestin2 TG mice while 32% was preserved in WT and 17% was preserved in βarrestin2 KO mice. We found the similar results in stroke volume (Fig. 2.2B). The similar results
were observed by echocardiography analysis (data not shown). Taken together, overexpression
of β-arrestin2 attenuates sepsis-reduced cardiac output and stroke volume.
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Figure 2.2. Overexpression of β-arrestin2 in mice attenuates CLP-reduced cardiac output and
stroke volume. We subjected WT, β-arrestin2 KO and β-arrestin2 TG mice (n = 6 per group) to
CLP or sham operations. At 6 h CLP, hemodynamic parameters were measured by cardiac
functional analysis. (A) CO, cardiac output. (B) SV, stroke volume. (C) HR, heart rate. *P <
0.01.
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β-arrestin2 Overexpression Attenuates Sepsis-reduced End-diastolic Volume (EDV).
End diastolic volume (EDV) represents the extent of ventricular filling in sepsis induced cardiac
dysfunction. EDV decreased by 39.6% and 49.5% in WT and β-arrestin2 KO mice after CLP
(Fig. 2.3A), respectively. Importantly, EDV decreased by only 16.6% in β-arrestin2 TG mice.
Therefore, β-arrestin2 over expression significantly blocks sepsis-reduced EDV. Either sepsis or
β-arrestin2 did not have an effect on LV end-systolic volume (ESV) (Fig. 2.3B). The similar
results were obtained by echocardiography analysis (Table 2).
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Figure 2.3 β-arrestin2 overexpression in mice diminishes CLP-reduced end diastolic volume
(EDV). WT, β-arrestin2 KO and β-arrestin2 TG mice (n = 6 per group) were subjected to CLP or
sham operations. Hemodynamic parameters were determined by cardiac functional analysis 6 h
after CLP as in Fig. 2.2. (A) EDV, LV end-diastolic volume. (B) ESV, LV end-systolic volume.
*P < 0.05.

Overexpression of β-arrestin2 Enhances Left Ventricular Contractility following
CLP. We then measured left ventricle pressure-related parameters after sepsis in WT, β-arrestin2
KO, and β-arrestin2 TG mice (Table 1). End systolic pressure (ESP) was severely reduced in βarrestin2 KO mice after sepsis (36 mmHg) as compared to sham mice (71 mmHg). In contrast,
ESP was slightly increased in septic WT mice (105 mmHg) and maintained in β-arrestin2 TG
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mice (90 mmHg). However, the end diastolic pressure (EDP) was not changed in CLP treated
groups. In addition, β-arrestin2 TG mice showed less decrease in dP/dtmax and dP/dtmin after
sepsis (decrease by 15 % and 5 %, respectively) compared to WT mice (decrease by 37 % and 29
%, respectively) and β-arrestin2 KO mice (decrease by 70 % and 72 % respectively).

Table 1 Cardiac systolic and diastolic functions 6h after cecal ligation and puncture.

WT

Parameter

KO

Sham

CLP

EF, (%)

66±1.8

37±2.7

ESP, mmHg

91±2.9

105±3.6

EDP, mmHg

7±1.2

4±0.9

6 ±0.7

104±3.2

75±3.1

LVDevP, mmHg 92±3.4

*
*

mmHg/s
Ea (mmHg/µL)

Sham

CLP

66±1.6

25±2.4
36±3.3

71±4.3

*

Sham

CLP

‡†

63±1.5

56±1.2

§†

†

97±4.5

90±1.8

†

6±0.9

6±1.1

97±3.8

89±3.1

8320±535

7±1.4
*

34±4.0

‡†

†

*

5647 ±529

*

1702±153

‡†

9782±544

9143±490 6524±451

*

4713 ±381

*

1310±150

‡†

7863±324

4.2±0.27

*

3.5 ±0.30

10.3±1.01

‡†

4.8±0.38

6.2±0.29

9.6±0.46

20.4±2.04

‡†

7.6±0.40

8.0±0.48

dP/dtmax, mmHg/s 10209±956 6393±191

dP/dtmin,

TG

Tau-Weiss (msec) 7.0±0.52

14.7±1.11
9.2±0.55

*

†

7468±318
†

Values present with means (±SEM). N=6 for each group. *: P < 0.05, versus WT-Sham; †: P <
0.05 versus WT-CLP; ‡: P < 0.05 versus KO-Sham; §: P < 0.05 versus TG-Sham. EF, ejection
fraction; ESP, LV end-systolic pressure; EDP, LV end-diastolic pressure; LVDevP, LV
developed pressure = Pmax-Pmin.
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Increased β-arrestin2 Expression in Septic Heart
To investigate the anti-apoptotic effect of β-arrestin2, we first examined the expression
level of β-arrestin2 in heart tissue following sepsis. Although elevated cardiac β-arrestin2
expression was observed in both WT and β-arrestin2 TG mice during sepsis, β-arrestin2
expression was still higher in TG mice (Fig. 2.4). The interference of β-arrestin2 expression from
non-residential cells (blood cells, macrophages) in heart was minimized by sufficient saline rinse
before and after tissue harvest.
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Figure 2.4 β-arrestin2 expression in septic heart. The protein level of β-arrestin2 in saline rinsed
heart tissue from mice 6h hour after treated with Sham or CLP were examined by Western blot
with loading control GAPDH. Data are representative of at least three independent experiments.
Values present means ± S.E.M.). *P < 0.05 were considered significantly different.

Effect of β-arrestin2 on the Levels of Phospho-gp130 and Phospho-p38 MAPK following CLP
Glycoprotein 130 (gp130), a key signal transducer, has been considered to be involved
in sepsis (24). Hence, we studied gp130 activation in the myocardium of β-arrestin2 KO and βarrestin2 TG and WT mice following CLP. At 6 h after CLP, the levels of gp130 Ser782
phosphorylation were significantly enhanced in septic WT and β-arrestin2 KO mice compared
with their control mice (Fig. 2.5A). Interestingly, the activation of gp130 was strikingly
decreased in β-arrestin2 TG septic mice as compared with WT and β-arrestin2 KO mice.
We recently reported that β-arrestin2 inhibits Toll-like receptor 4 by targeting p38 in
lipopolysaccharide-stimulated cell culture studies (18). The effect of β-arrestin2 on p38
activation (phospho-p38) in sepsis remains to be elucidated. In the present study, we tested
whether p38 activation can be modulated by β-arrestin2 in the myocardium of CLP mice. Fig.
2.5B shows that CLP-induced sepsis significantly enhanced the level of phospho-p38 in WT and
β-arrestin2 KO mice, compared with sham control. Notably, overexpression of β-arrestin2
prevented CLP-enhanced myocardial phospho-p38 levels.
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*

Figure 2.5 Overexpression of β-arrestin2 in mice blocks CLP-induced the levels of gp130 and
p38 phosphorylation. WT, β-arrestin2 KO and β-arrestin2 TG mice (N = 6 per group) were
subjected to CLP or sham operations as in Fig. 2. After cardiac functional analysis, hearts were
harvested and cellular proteins were prepared. The levels of phosphorylation of gp130 (A) and p
38 (B) were determined by Western blot with specific antibodies. Representative results are
shown above the graph. *P < 0.05.

Results showed p38 and gp130 can still be phosphorylated in inflammation-induced myocardial
depression in the absent of β-arrestin 2, which is consisted with the impaired cardiovascular
function in both WT and β-arrestin 2 knockout mice. Results of β-arrestin 2 knockout suggested
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β-arrestin 2 was not an essential mediator in the development of uncontrolled inflammation.
Further than that, WT level of β-arrestin 2 expression was unable to prevent the CLP-induced
stimulation of signaling transduction pathways mediated by p38 and gp130. Only β-arrestin 2
overexpression before sepsis showed positive results in anti-inflammation.
Phosphorylation of gp130 on Ser782 accelerated the internalization of membrane-bound
gp130 (28). Our results showed correlated beta-arretin2 overexpression and phosphorylation of
gp130 in TG mice following sham treatment, which indicated a ligand-independent regulation of
IL-6 receptors by β-arrestin 2.
Our results suggested lowered threshold for the activation of p38 due to overexpression of βarrestin 2. Therefore, the mild stimulation of sham treatment was able to moderately enhance p38
phosphorylation in TG mice compared to WT and knockout mice. The molecular mechanism
between β-arrestin 2 and p38 is unknown.

The Effect of β-arrestin2 on STAT3 Phosphorylation after Sepsis.
To understanding the signaling pathway downstream to gp130, we then examined levels of
phosphorylated STAT3 (Tyr705 and Ser727), a possible effector of gp130 mediated signaling
pathway in septic myocardium (24).
Results showed STAT3 phosphorylation at Tyr705 was dampened in KO mice (Fig. 2.6.),
indicating β-arrestin 2 was required in STAT3 Tyr705 phosphorylation. STAT3 Ser727
phosphorylation was enhanced in all three genotypes after CLP including KO group, suggesting
the involvement of β-arrestin 2 independent inflammatory signaling pathways.
In consist with increased gp130 phosphorylation in TG mice with sham treatment,
increased STAT3 phosphorylation on Ser727 was also observed.
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However, STAT3 phosphorylation on Tyr705 was not elevated in TG sham group.
The unbalanced STAT3 phosphorylation on two sites suggested different signaling transduction
pathways were involved.

Figure. 2.6. β-arrestin2 expression promotes anti-apoptotic STAT3 activation after sepsis. Total
or phosphorylation level of STAT3 were examined by Western blot with loading control
GAPDH. Data are representative of at least three independent experiments. Values present
means (±S.E.M.). *: P < 0.01.

The Effects of β-arrestin 2 on ERK and JNK Phosphorylation after Sepsis.
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As shown in results above, p38 MAPK activation was regulated by β-arrestin 2. To explore
possible downstream effectors of β-arrestin 2 after CLP-induced myocardial dysfunction, we also
examined the phosphorylation level of ERK and JNK. Increased activation of both ERK and
JNK activation was observed after CLP-induced sepsis. However, the results of phosphorylation
were not correlated the expression level of β-arrestin 2 in both sham and CLP treated conditions
(Fig. 2.7). Therefore, at the time point of 6 hour after CLP, ERK and JNK were unlikely the
downstream effectors of β-arrestin 2.

Figure 2.7 The role of β-arrestin 2 in CLP-induced ERK and JNK phosphorylation . WT, βarrestin 2 KO, and β-arrestin 2 TG mice (N = 6 per group) were subjected to CLP or sham
operations as in Fig. 2. After cardiac functional analysis, mice hearts were harvested and cellular
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proteins were prepared. The levels of phosphorylation of ERK (A) and JNK (B) were determined
by Western blot with specific antibodies. Representative results are shown above the graph. *P <
0.05.
Cardiac Preload was Maintained in β –arrestin2 Overexpression Mice after CLP Induced Sepsis
in Echocardiography Studies.
In order to measure heart function in a non-invasive manner, echocardiography was
performed on β –arrestin2 KO, TG and WT mice before and after CLP induced sepsis. The
results were consist with invasive measurements in that β –arrestin2 TG mice showed preserved
cardiac preload (LVEDD) compared to KO and WT mice (Table 2) .

IL-6 expression is not Affected in β –arrestin2 Overexpression Mice after CLP induced sepsis.
IL-6 is a potent cardiomyocyte depressor, which is vigorously produced in early sepsis.
Directed myocyte contractility inhibition was observed in serum containing IL-6, while the
inhibitory effect is absent in serum containing only TNFα or IL-1β (36-37). Sequestering IL-6 by
antibodies could restore myocyte contractility. Therefore targeting IL-6 expression or
downstream signaling conductors may provide therapeutic effects on SIMD. IL-6-induced
myocyte depression and dampened inotropic responsiveness is reversible by p38 inhibition in
isolated human myocytes. Cardiomyocytes overexpressing mutant p38 are resistant to IL-6
induced myocyte depression, which indicated the requirement of activated p38 for the
deleterious effect of IL-6. Additionally, our previous study showed β-arrestin2 inhibited Toll like
receptor 4 via targeting p38 MAPK in LPS stimulated cell culture studies (18). Increased cell
survival after nutrient deprivation is also indicated in β-arrestin2 transfected cells, inhibited p38
phosphorylation was observed. We hypothesis β-arrestin2 overexpression may regulate IL-6
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pathway through p38 in CLP induced sepsis. In this study, we found that IL-6 levels in all three
genotype groups were increased 6 h after sepsis (Fig. 2.8)
Table 2. Beta-arrestin-2 over-expression affected cardiac preload (venous return) in mice
during sepsis induced by cecal ligation and puncture.
Time Relative to Cecal Ligation and Puncture
WT
Index

KO

TG

Before

After

Before

After

Before

505 ±38

462 ± 78

500 ± 59

363 ± 38b

492 ± 32

54 ± 6

57 ± 13

57 ± 2

60 ± 14

57 ± 8

67± 11

FS, %

27.3 ± 3.73

29.0 ±8.06

29.5 ± 1.68

31 ± 11.31

29.8 ±5.07

36.4 ± 7.55

LVEDD, mm

3.8 ± 0.27

2.9 ± 0.51a

3.9 ± 0.07

2.2 ± 0.38b

3.8 ± 0.11

3.1 ± 0.48

LVESD, mm

2.8 ± 0.31

2.1 ± 0.60a

2.8 ± 0.07

1.6 ± 0.38

2.7 ± 0.26

2.0 ± 0.47

LVEDV, µL

64± 11

32 ± 13a

66 ± 3

18 ± 7

63 ± 8

40 ± 15

LVESV, µL

30 ± 8

14. ± 11a

28 ± 2

7±3

26 ± 6

16 ± 10

33 ± 4

18 ± 4a

38 ±3

10. ± 5b

37 ± 3

24. ± 5b

16800 ±

7879 ±

18739 ±

3756 ±

18291 ±

12209 ±

1816

1877a

1907

1654b

1631

2681b

Heart

rate,

beats/min
Ejection
fraction, %

Stroke
volume, µL
Cardiac
output,
/min

µL

After
500 ± 45

Data are mean ± SEM. There were 9 mice in each group. Cardiac function was measured by
echocardiography before and 6 hours after cecal ligation and puncture. Abbreviations: FS,
fractional shortening index; LVEDD, left ventricular end-diastolic diameter; LVESD, left
ventricular end-systolic diameter; LVEDV, left ventricular end-diastolic volume; LVESV, left
ventricular end-systolic volume. a P < 0.05, compared with before CLP in WT group. b P < 0.05,
compared with after CLP in WT group.
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Figure 2.8. IL-6 serum levels were examined by ELISA. Serum was collected from WT, βarrestin2 KO and β-arrestin2 TG mice 6h after CLP. Cytokine level was measured in serum
using ELISA. Values present means ± SEM, n=4 for CLP and Sham groups in IL-6 level
analysis. #P < 0.05 were considered significantly different.

Decreased Cardiomyocyte Apoptosis in β –arrestin2 Overexpression Mice
TUNEL staining was used to evaluate apoptosis in heart tissue. We found 27% apoptotic
cells in WT, 29% in KO but only 15% in TG tissues after sepsis (Fig. 2.9). These data are
consistent with the report that heart function change in early sepsis could predict prognosis since
TG mice showed better cardiac performance.
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Figure 2.9. Overexpression of β-arrestin2 attenuated sepsis-induced apoptosis in the heart. WT,
β-arrestin2 KO and β-arrestin2 TG mice were subjected to CLP or Sham operations, and then
sacrificed 6 h later. Apoptotic cells from heart section were examined by TUNEL staining (A).
Dark brown spots represent apoptotic nuclei and red spots represent normal nuclei. Arrows point
to the representative apoptotic nuclei. Bar scale 50µm. B, statistical analysis of TUNEL positive
cells. n=3 for each group. Values present means ±SEM. # P <0.05, compared to Sham group; a P
<0.05, compared to WT group;

b

P <0.05, compared to KO group. P <0.05 were considered

significantly different.
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Discussion
Sepsis is a major clinical problem, and the mortality rate is over 40 percent (1,3). Sepsis is
the No.1 cause of morbidity and mortality in intensive care units (ICUs), and about 60% of
patients admitted to the ICU have cardiac dysfunction (2-4,23). Cardiac dysfunction plays a
fundamental role in the high morbidity and mortality of this condition (2-4,23 ). Thus, it is urgent
to elucidate the mechanisms by which sepsis modulates cardiac dysfunction and generate more
efficient ways to improve the prognosis. In this study, we have demonstrated that β-arrestin2
plays a critical role in the regulation of sepsis-triggered cardiac dysfunction through gp130 and
p38 MAPK. Following sepsis, overexpression of β-arrestin2 in mice increases animal survival.
Importantly, β-arrestin2 overexpression in mice abolishes sepsis-induced cardiac dysfunction.
The role of β-arrestin2 in regulating gp130 and p38 MAPK activation is significant, as βarrestin2 overexpression results in lower gp130 and p38 phosphorylation after sepsis stimulation.
Our results implicate that overexpression of β-arrestin2 may form the basis of a new strategy for
the clinical treatment of sepsis.
Increasing evidence suggests that β-arrestin2 can modulate inflammatory responses through a
few mechanisms. For instance, β-arrestin2 modulates immune functions during the development
of allergic asthma (25). Another prior study indicates that β-arrestin2 participates in the
regulation of inflammatory responses in sepsis (26). In previous studies, sepsis was associated
with decreased cardiac output, decreased end diastolic volume or diastolic diameter, and
decreased ejection fraction (EF). Decreased heart contractility was found 18 h as well after CLP
using Millar instruments for cardiac functional analysis (23). In our study, WT mice showed
significant cardiac dysfunction 6 hours after CLP, consistent with results of these studies (23,27).
Impaired vascular contractility and decreased sympathetic tone in sepsis has been demonstrated
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in several studies (3,27). In this study, we also confirmed the involvement of vascular factors by
echo-cardiovascular measurement before CLP and 6 hours after CLP (n = 9). We found
decreased cardiac output after sepsis, most likely due to combined cardiomyocyte dysfunction
and decreased cardiac preload. The decreased mortality and preserved cardiac function in βarrestin2 overexpression mice suggests that agents increasing β-arrestin2 expression may protect
the cardiac and vascular system from sepsis-induced injury. In the present study, we found that
overexpression of β-arrestin2 increases animal survival in sepsis. Notably, a new and novel role
for β-arrestin2 was revealed in the prevention of sepsis-induced cardiac dysfunction. Thus,
attenuation of cardiac dysfunction might be a primary mechanism by which β-arrestin2 enhances
animal survival during sepsis. While investigating the role of β-arrestin 1 in cardiac dysfunction
induced by sepsis beyond the scope of the current study and will be elucidated in future research.
Cardiac β-arrestin2 expression in TG mice is around two fold of that found in WT mice
without CLP with increased β-arrestin2 expression after CLP in both TG and WT mice. It may
be a self-protective mechanism to increase the protein level of β-arrestin2 during inflammatory
injury. This study showed moderately attenuated cardiac dysfunction in WT mice compared to
significantly compromised cardiac function β-arrestin2 KO mice. However, elevated β-arrestin2
expression in WT mice is not associated with significantly improved final survival rate. These
results suggest increasing β-arrestin2 expression before CLP may be more important for
prognosis.
In this study, we examined phosphorylation of gp130, a key signal transducer. We found
that significantly decreased levels of gp130 phosphorylation in the myocardium in β-arrestin2
TG mice following CLP while the opposite results shown in WT and β-arrestin2 KO mice.
Gp130 phosphorylation at Ser782 is involved in the internalization of membrane-bound gp130
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(28). Recent studies have shown that β-arrestin2 functions as an adaptor to connect the receptors
to the cellular trafficking machinery, such as scaffolding GPCRs activation (18,22), as well as
the signal transduction not related to GPCRs such as Toll-like receptors (8,18,30–33). Beside its
function in facilitating receptor internalization, β-arrestin2 can scaffold different sets of
molecules that lead to distinct and even opposite effects on the same signaling cascade dependent
on the receptor activated (29, 30). Our studies show that in the septic animal model, the
overexpression of β-arrestin2 reduces phospho-gp130, associating with more survival. Our
results suggest a possible connection between β-arrestin2 and gp130 internalization. Our studies
did not determine the specific membrane receptors that are involved in the modulation of βarrestin2 phosphorylation gp130 in sepsis. Identifying the specific membrane receptors is beyond
the scope of the current study and will be investigated in future..
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Figure 2.10. The predicted role of β-arrestin2 in septic heart. β-arrestin2 overexpression may
positively regulate STAT3 phosphorylation via inhibiting p38 phosphorylation and subsequent
gp130 phosphorylation (internalization) through unknown mechanisms. ETC: electron transport
chain; ROS: reactive oxygen species; GPCR: G protein coupled receptor; solid arrow: direct
effect; dashed arrow: indirect effect; ?: unknown mechanisms.
IL-6 is continuously expressed and maintained at high levels after sepsis; thereby it serves
as a better clinical molecular marker than IL-1β and TNFα in determining the severity of this
disease, especially for heart dysfunction (36-37). The controversy on expression levels of
cytokines after CLP mostly likely due to the different time point of the measurement, the
sensitivity of the cytokine measurement kit/instrument, or the severity of the sepsis model. In
this study, serum IL-6 level was about 20ng/ml 6 h after CLP and unexpectedly uniform within
and between different genotypes, which indicates the initiation of IL-6/ IL-6R/ gp130/JAK2
/STAT3 pathway is beyond the regulation of β-arrestin2. Recently, β-arrestin2 has been reported
to regulate the internalization and signaling transduction of chemokine receptors during
inflammation. In this study, we established a connection between β-arrestin2 and gp130, a
common IL-6 receptor and functional signal transducer. We found β-arrestin2 overexpression
inhibited gp130 Ser782 phosphorylation that might result in decreased receptor internalization
and increased downstream STAT3 activation.
STAT3 has been revealed to induce tumor genesis in a Ras-dependent manner (32). But
the anti-apoptotic effect of STAT3 is beneficial for an acute inflammatory response. STAT3 is
the downstream effector of various signaling cascades including but not limited to the IL-6mediated pathway. Therefore, the enhanced STAT3 Tyr705 phosphorylation may be the
combined result of JAK2 and other tyrosine kinases such as Src (33-35). Our result also
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indicated β-arrestin2 scaffold protein Akt is not the principal regulator for STAT3 on Ser727
activation in cytoplasm. It would be interesting to investigate whether β-arrestin2 could interact
with STAT3.
P38 and ERK, members of the MAPKs family, are essential cellular protein kinases. They
can be activated by a series of extracellular signals and then induce cell responses, including cell
proliferation, differentiation, survival and apoptosis (22). Activation of p38 and ERK modulates
different cell responses depending on the stimulus (22, 31). However, the effect of β-arrestin2 on
p38 and ERK activation in sepsis remain to be established. In the current study, we observed that
CLP significantly induced p38 phosphorylation in the myocardium in WT and β-arrestin2 KO
mice. Interestingly, the level of phospho-p38 was diminished in β-arrestin2 TG mice following
CLP. However, we observed that β-arrestin2 was not involved in ERK phosphorylation in the
myocardium following CLP. All together, these results suggest that β-arrestin2 may specifically
decrease myocardial p38 phosphorylation during sepsis (Fig 2.10.).
Previous studies have suggested p38 as a crucial modulator for gp130 Ser782
phosphorylation and internalization in the crosstalk between IL-1β and IL-6 signaling pathways
during inflammation (28). In acute inflammation of sepsis, overestimation of the IL-6 signaling
pathway, which is mediated by gp130, could be negatively regulated by the activation of p38. On
the other side, p38 activation could be controlled by β-arrestin 2 in various conditions. Without
inflammation, stress-induced p38 activation could be facilitated by the overexpression of βarrestin 2, which might serve as an explanation for moderately increased p38, gp130, and STAT3
phosphorylation in the sham group of transgenic mice. During sepsis, p38 activation could be
achieved by β-arrestin 2 dependent as well as β-arrestin 2 independent pathways, followed by
accelerated gp130 phosphorylation/internalization and STAT3 activation. However, we suspect
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an opposite function of β-arrestin 2 on p38 activation, when the accumulation of β-arrestin 2
exceeds the threshold, which could serve as a signal or a direct effector for the suppression of
p38 activation. At 6 hour after CLP, the suppression of p38 action was first achieved in βarrestin 2 transgenic mice. Although the network among p38, β-arrestin 2, and gp130 could be
complicated and variable in the development of sepsis, evidence revealed from this work could
still serve as a useful clue for future studies.
In summary, the data presented herein demonstrated for the first report, to the best of our
knowledge, a vital role for β-arrestin2 in sepsis-induced cardiac dysfunction. The protective
effects could be mediated at least partially by down-regulation of gp130 and p38 activation in βarrestin2 TG mice. These findings implicate the beneficial effect of β-arrestin2 overexpression in
sepsis and open a novel promising target for the management of sepsis.
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Abstract
Stem-cell antigen 1–positive (Sca-1+) cardiac stem cells (CSCs), a vital kind of CSCs in
humans, promote cardiac repair in vivo and can differentiate to cardiomyocytes with 5’azacytizine treatment in vitro. However, the underlying molecular mechanisms are unknown. βarrestin2 is an important scaffold protein and highly expressed in the heart. To explore the
function of β-arrestin2 in Sca-1+ CSC differentiation, we used β-arrestin2-knockout mice and
overexpression strategies. Real-time PCR revealed that β-arrestin2 promoted 5’-azacytizineinduced Sca-1+ CSC differentiation in vitro. Because the microRNA 155 (miR-155) may
regulate β-arrestin2 expression, we detected its role and relationship with β-arrestin2 and
glycogen synthase kinase 3 (GSK3β), another probable target of miR-155. Real-time PCR
revealed that miR-155, inhibited by β-arrestin2, impaired 5’-azacytizine-induced Sca-1+ CSC
differentiation. On luciferase report assay, miR-155 could inhibit the activity of β -arrestin2 and
GSK3β, which suggests a loop pathway between miR-155 and β-arrestin2. Furthermore, βarrestin2-knockout inhibited the activity of GSK3β. Akt, the upstream inhibitor of GSK3β was
inhibited in β-arrestin2-knockout mice, so the activity of GSK3β was regulated by β-arrestin2
not Akt. We transplanted Sca-1+ CSCs from β-arrestin2-knockout mice to mice with myocardial
infarction and found similar protective functions as in wild-type mice but impaired arterial
elastance. Furthermore, low level of β-arrestin2 agreed with decreased phosphorylation of Akt
and increased phosphorylation of GSK3β, similar to in vitro findings. The β-arrestin2/miR-155/
GSK3β pathway may be a new mechanism with implications for treatment of heart disease.
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Introduction
Acute myocardial infarction, characterized by the irreversible necrosis of cardiac cells,
causes a significant number of deaths every year. The clinical trials of stem cells transplantation
have not been consistent because these cells either do not differentiate into cardiac cells or
differentiate into only limited number of cardiac cells. More recently, direct differentiation of
resident cardiac stem cells (CSCs) into cardiomyocytes has given new hope for myocardial
regeneration (1–3). However, the mechanisms of CSCs differentiation into cardiomyocytes are
little known.
Several kinds of resident CSCs, including stem-cell antigen 1–positive (Sca-1+), c-kit+
and side-population cells, have been identified in adult hearts (2, 4). Transplantation of Sca-1+
into the infarcted area of hearts promotes cardiac repair (5, 6), which indicates a key role of Sca1+ resident CSCs in CSC differentiation and therapy. Recently, Sca-1+ cells were found to
different into cardiomyocytes after treatment with 5-azacytidine (5aza) in vitro (7, 8), this model
helps in exploring the underlying mechanisms of Sca-1+ cell differentiation into cardiomyocytes.
β-arrestins, abundantly expressed in cardiac muscle, are well- known negative regulators of
G-protein-coupled receptor signaling and function as scaffold proteins to modulate G-proteinindependent signal cascades. β-arrestins consist of two proteins: β-arrestin1 and β-arrestin2
(Arrb2). The expression of Arrb2 is induced in the failing heart (9), and recent studies point to
the beneficial role Arrb2 plays in the heart (10). However, the direct function and the mechanism
of Arrb2 mediated Sca-1+ CSC differentiation is not known yet.
MicroRNAs (miRNAs) are small 20- to 24-nt non-coding RNAs found in diverse
organisms. They have a broad impact on gene expression via translational repression or posttranscriptional suppression (11). TargetScan analysis showed that many miRNAs might regulate
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Arrb2. MiR-155 is a probable miRNA regulating Arrb2. Furthermore, miR-155 was greatly
down-regulated in a myocardial infarction model (12, 13), so miR-155 might have a protective
function in cardiac injury. However, whether miR-155 participates in Arrb2–regulated Sca-1+
cell differentiation is not clear.
In this study, we explored the mechanism of Arrb2 mediated Sca-1+ CSC differentiation,
and found β-arrestin2/miR-155/GSK3β pathway regulates transition of 5’-azacytizine-induced
Sca-1+ cells to cardiomyocytes, which might be a new target for the treatment of heart disease.
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Material and Methods
Regents
5aza and PKH2 green fluorescent cell linker kit were obtained from Sigma-Aldrich (St.
Louis, MO, USA). Lipofectamine 2000, and SYBR GreenER were from Invitrogen (Grand
Island, NY, USA). The MMLV reverse transcription system and dual luciferase reporter assay
system were from Promega (Madison, MI, USA). TaqMan MicroRNA Assay, TaqMan
MicroRNA Reverse Transcription kit, and TaqMan Universal PCR Master Mix were from
Applied Biosystems (Foster, CA, USA). Anti- bodies, including total and phospho-GSK-3β (Ser
9), total and phospho- Akt (Ser 473), were from Cell Signaling Technology (Beverly, MA,
USA). Biotinylated Sca-1 antibody was from BD Biosciences (San Jose, CA, USA). Antibodies
for GAPDH and Arrb2 were from Santa Cruz Biotechnology (Santa Cruz, CA, USA). The
cardiac troponin T (cTnT) antibody was from Abcam (Cambridge, UK). GSK-3β inhibitor
SB216763 was from Tocris Bioscience (Bristol, UK).
Animals
10–12 weeks Arrb2-KO mice on a C57BL/6J background were provided by Dr. Robert J.
Lefkowitz (Duke University Medical Center, Durham, NC). Wild-type (WT) C57BL/6J male
mice were obtained from the Jackson Laboratory (Bar Harbor, ME, USA). All mice were
maintained in the Division of Laboratory Animal Resources at East Tennessee State University
(ETSU), a facility accredited by the Association for the Assessment and Accreditation of
Laboratory Animal Care International. Animal care and experimental protocols were approved
by the ETSU Committee on Animal Care.
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Cell Culture
Cardiac Sca-1+ cells were isolated by magnetic cell sorting from C57BL/ 6 or Arrb2
knockout mice (10- to 12-week-old, C57BL/6 background) with about 98% purity, as described
previously (14). Briefly, hearts from adult mice were treated with 0.1% collagenase for 30 min.
followed by filtering through 80 µm mesh. To separate Sca-1+ cells, cells were incubated with
biotinylated anti-Sca-1 antibody (BD Biosciences) for 15 min. on ice and washed with IMag
buffer (consisting of PBS with 0.5% bovine serum albumin and 2 mM EDTA) followed by
incubation with streptavidin-conjugated particles for 30 min. on ice. Newly isolated cardiac Sca1+ were cultured on 1% gelatin-coated dishes with Iscove’s modified Dulbecco’s medium
supplemented with 10% fetal bovine serum (FBS), 100 µg/ml penicillin, and 250 µg/ml
streptomycin at 37°C in humid air with 5% CO2. The separated Sca-1+ CSCs were lack of the
hematopoietic stem cell markers CD45 and CD34 (also a marker of endothelial progenitor cells)
and hematopoietic transcription factors Lmo2, Gata2 and Tal (2). At 1 day after seeding, cells
were treated with 10 µM 5aza for the first 3 days; the medium was changed every 3 days. The
dose and time of treatment with 5aza was reported previously (7, 8). Human HEK293T cells
were purchased from American Type Culture Collection (USA).

Cell Transfection and Plasmids
Sca-1+ cells (3.5 ×105) in 350 µl gene pulse electroporation buffer with 40 µg/ml DNA
were transferred into a 0.4-cm cuvette. After a pulse at 200 V, 250 µF, 1000 Ω, 10 ̋ with Bio-Rad
MXcell (Bio-Rad, Hercules, CA, USA), cells were transferred to 1% gelatin-coated wells of a
24-well tissue culture plate containing 500 µl growth medium. Cells were incubated with
Iscove’s modified Dulbecco’s medium supplemented with 10% FBS and 10 µM 5aza for the first
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3 days, then normal culture medium. Arrb2 full-length and control vectors were generous gifts
from Dr. Gang Pei (Shanghai Institutes for Biological Sciences).
Real-time PCR (RT-PCR)
Total RNA was extracted and reverse-transcribed into cDNA. Quantified RT-PCR was
involved use of SYBR GreenER on the Bio-Rad PCR instrument. PCR reaction conditions were
according to the standard protocol. GAPDH was used as an endogenous control. All real-time
PCR reactions were performed in triplicate, and relative quantification involved the Delta Delta
Ct method (95% CI). All primer sets were subjected to a dissociation curve analysis and
produced single peaks on a derivative plot of raw fluorescence. Primer sequences for MYH6,
GATA4, cTnT and β-actin were as described (15).

Western Blot Analysis
Total proteins were extracted by use of RIPA lysis buffer (Pierce Biotechnology,
Rockford, IL, USA). Samples containing equal amounts of protein were separated by 8% SDSPAGE and transferred onto Hybond ECL membranes (Amersham Pharmacia, Piscataway, NJ,
USA), which were incubated overnight at 4°C with the appropriate primary antibodies (1:1000),
then incubated 1 hr at RT with peroxidase-conjugated secondary antibodies (1:5000). Blots were
exposed to the SuperSignal West Dura Extended Duration substrate (Pierce). Signals were
quantified by scanning densitometry with the Bio-Image Analysis System (Bio-Rad).

Luciferase Reporter Assay
HEK293T cells were seeded on 96-well plates the day before transfection in antibiotic-free
medium. Cells were cotransfected with 60 ng miR-155 plasmid or control plasmid and 100 ng
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psicheck2 3’-UTR-WT (WT Arrb2 or GSK3β 3’-UTR) or psicheck2 3’-UTR-MUT (mutant
miR-155 target site in Arrb2 or GSK3β 3’-UTR) by use of Lipofectamine 2000 (Invitrogen).
After 48 hrs, cells were collected for luciferase assay with the Dual Luciferase Assay kit on a
Modulus microplate. MiR-155 and control plasmids were generous gifts from Dr. Yangchao
Chen (Chinese University of Hong Kong). Luciferase constructs were generated by Geneway
Biotech Co. (Shanghai, China). Briefly, the entire 3’-UTR or 3’-UTR-MUT of Arrb2 and GSK3β genes were cloned into pBluescript SK vector and then cloned into psicheck2 vector.

Immunofluorescent Staining
Cells or tissue slides were fixed with 3.7% formaldehyde in PBS for 20 min. at RT and
stained with anti-cTnT antibody, then Alexa fluor 546-conjugated secondary antibody
(Molecular Probes, Eugene, OR, USA). Cells or slides were examined by use of the Olympus
IX70 microscope.

Myocardial Infarction-reperfusion (I/R) Injury and Cell Delivery
Male mice were anesthetized with 5% isoflurance and maintained by inhalation of 1.5%
isoflurance driven by 100% oxygen flow and ventilated by use of a rodent ventilator. Myocardial
infarction was induced as described (16). At 30 min. after left anterior descending ligation, 20 µl
basal IMEM medium without cells (control group) or with 2×105 Sca-1+ cells stained with
PKH2 green fluorescent cell linker kit (cell injection group) were injected into the infarction and
border zones of hearts by use of 29-gauge needles. After cell injection, hearts were reperfused
for 1 hr, the chest was sutured with silk and all mice were allowed to recover. At 14 days after
surgery, cardiac function was analyzed. Every group has six mice and sham mice were as a
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control. At the end of the experiment, mice were killed, and hearts were collected for western
blot analysis or were perfusion-fixed, embedded in paraffin, and cut transversely into 6–8 µm
thick sections at the level of the papillary muscle. Sections were stained with anti-cTnT antibody
and scanned.

Cardiac Function Analysis
Cardiac function was detected by use of the SPR-839 instrument (Millar Instruments,
Houston, TX, USA) (16). In anesthetized mice, systolic and diastolic arterial blood pressure was
recorded by means of a microtip pressure transducer inserted into the right carotid artery. The
catheter was then advanced into the left ventricle to measure cardiac functions in the closed-chest
preparation. Then cardiac tissues were harvested for western blot and real-time PCR analyzes.

Statistical Analysis
Data are reported as mean ± SEM and analyzed by one-way ANOVA followed by a HolmSidak post hoc analysis. Differences were considered statistically significant at P < 0.05.
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Results
β-arrestin2 Promoted 5aza-induced Cardiac Myocyte Differentiation in CSCs
The expression of cardiomyocyte markers showed that 5aza induced cardiac myocyte
differentiation in Sca-1+ CSCs at 3 weeks (Fig. 3.1A). So this time-point was used in our current
study. Arrb2 was up-regulated at both mRNA and protein levels at 3 weeks after 5aza treatment
(Fig. 3.1B and C). Furthermore, Arrb2 overexpression could increase the mRNA expression of
MYH6 and cTnT on RT-PCR and the level of cTnT on immunofluorescence assay (Fig. 3.1D
and E), which suggested that Arrb2 promoted 5aza-induced Sca-1+ cell differentiation to
cardiomyocytes.
To evaluate whether 5aza-induced Sca-1+ cell differentiation was through Arrb2, we used
Sca-1+ cells from Arrb2-KO mice. 5aza could not up-regulate the expression of cardiac cell
markers MYH6, GATA4 and cTnT in Sca-1+ cells from Arrb2-KO mice as compared with WT
mice (Fig. 3.1F), which suggests that 5aza induced Sca-1+ cell differentiation via an Arrb2–
dependent manner. Thus, we further determined the mechanisms responsible for Arrb2–
dependent differentiation of 5aza-treated Sca-1+ cells.
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Figure 3.1. Effect of Arrb2 on 5’-azacytizine-induced differentiation of cardiac stem cells
(CSCs) to cardiomyocytes. (A) Isolated Sca-1+ cells from wild- type (WT) mice were seeded 1
day before cells were treated with 5’-azacytizine (5aza) at 10 µM. After 3 days’ treatment, cell
culture medium was changed every 3 days for 2 and 3 weeks. Relative gene expression of
cardiomyocyte markers including MYH6, GATA4, and cTnT were detected by RT-PCR. (B and
C) isolated Sca-1+ cells from wild-type (WT) mice were treated with 5aza at 10 µM for 3 weeks.
Arrb2 expression was determined by RT-PCR (B) and western blot analysis (C). (D and E) Sca1+ cells from WT mice were transfected with full-length Arrb2 or control vector. After 24 hrs,
cells were treated with 5aza as in A; the level of cTnT was detected by fluorescence assay (D)
and the expression of MYH6, GATA4 and cTnT by RT-PCR (E). (D) It shows phase-contrast
(transmission) and fluorescence images. GFP shows transfected cells; scale bar = 15 µm. (F)
Sca-1+ cells from WT and Arrb2-knockout (KO) mice were treated with 5aza as in A. Real-time
PCR analysis of the mRNA levels of MYH6, GATA4, and cTnT. Data are mean ± SEM of three
experiments. *P < 0.05; **P < 0.01.
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MiR-155 Inhibited 5aza-induced Myocardiac Differentiation and was Regulated by β-arrestin2
MiR-155 is a potential regulator for Arrb2 expression as suggested by analysis with
Targetscan. We found miR-155 level decreased in CSCs after 3 weeks of 5aza treatment (Fig.
3.2A). To study the role of miR-155, we generated a construct expressing miR-155.
Overexpression of miR-155 rescued the increased expression of the cardiac marker cTnT (Fig.
3.2B), so miR-155 inhibited the myocardiac differentiation.
To determine the relationship between miR-155 and Arrb2, we detected the changes in
miR-155 level in Arrb2–transfected Sca-1+ CSCs by RT-PCR. Arrb2-KO inhibited the level of
miR-155 in WT cells (Fig. 3.2C), which supports a relationship between Arrb2 and miR-155.
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Figure 3.2 MiR-155 inhibits 5aza-induced differentiation of CSCs into cardiomyocytes through
Arrb2. (A) RT-PCR analysis of the expression of miR-155 in Sca-1+ cells from WT mice treated
as in Figure 3.1A. (B) Sca-1+ cells from WT mice were transfected with miR-155 plasmid or
empty plasmid control. After 24 hrs, cells were treated with 5aza and the expression of MYH6
and cTnT was examined by RT-PCR. (C) Sca-1+ cells from WT and Arrb2-KO mice were
treated with 5aza and miR-155 expression was examined as in A. Data are mean ± SEM of three
experiments. **P < 0.01.
The potential target site for miR-155 interaction is at nucleotides 145-151 of the mouse
Arrb2 3’-UTR as suggested by analysis with Targetscan (Fig. 3.3A). To test whether miR-155
could directly target the 3’-UTR of Arrb2 mRNA in a sequence-specific manner, we generated a
luciferase construct harbouring a potential binding site for miR-155 and produced a mutant
construct with potential target sites mutated (Fig. 3.3B). Luciferase activity decreased
significantly in cells transfected with luc-β-arrestin2 on cotransfection with miR-155, with no
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significant difference in luciferase activity on cotransfection with the mutated construct and miR155 (Fig. 3.3C). So miR-155 might target Arrb2 and inhibit its expression, but because Arrb2
will inhibit the expression of miR-155. Thus, there is a loop pathway between Arrb2 and miR155 to maintain the function of Arrb2 promoting CSC differentiation.

Figure. 3.3 Arrb2 is a miR-155 target. (A) Sequence alignment of miR-155 and its target site in
the 3’-UTR of Arrb2 (downloaded from http://www. targetscan.org). (B) The seed region of
Arrb2 3’-UTR was mutated as indicated. (C) HEK293T cells were cotransfected with 60 ng
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miR-155 plasmid or empty EGFP plasmid control and 0.1 µg psicheck2 3’-UTR- WT (WT
Arrb2) or psicheck2 3’-UTR-MUT (mutant miR-155 target site in Arrb2 3’-UTR). Cells were
collected 48 hrs after transfection and analyzed by dual luciferase reporter assay. The psicheck2
vector that provided the constitutive expression of Renilla luciferase was cotransfected as an
internal control. Data are mean ± SEM of four experiments. **P < 0.01.

GSK3β is Required for 5aza-mediated Myocardiac Differentiation and Targeted by MiR-155
To clarify the downstream molecule of miR-155, we analyzed the function of GSK3β,
another probable target of miR-155, determined via Targetscan, in 5aza-induced differentiation.
Computational analysis indicated that miR-155 potentially targets mouse GSK3β at nucleotides
4863-4869 and 265-271 (Fig. 3.4A). We generated luciferase constructs harboring two potential
binding sites for miR-155 and produced a mutant construct with potential target sites mutated
(Fig. 3.4B). Luciferase activity decreased significantly in luc-GSK3β–transfected cells on
cotransfection with miR-155, with no significant difference on cotransfection with the mutated
construct and miR-155 (Fig. 3.4C). So GSK3β is the target of miR-155.
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Figure.3.4 MiR-155 targets GSK3β. (A) Two possible GSK3β sites could be targeted by miR155 as in Figure 3.3A. (B) The seed regions of GSK3β 3’-UTR were mutated as indicated. (C)
Luciferase assay of psi- check2 3’-UTR-WT (WT GSK3β) or psi- check2 3’ -UTR-MUT
(mutant miR-155 target site in GSK3β 3’-UTR) and others measured as in Figure 3.3C. Data are
mean ± SEM of four experiments. **P < 0.01.

To determine the function of GSK3β, we treated Sca-1+ cells with its inhibitor,
SB216763, at 10 µM, together with 5aza for the first 3 days. The effective concentration was as
described previously and in our preliminary experiment (17). SB216763 could inhibit the 5azainduced expression of cardiac markers (Fig. 3.5A), which suggested that the activity of GSK3β
was required for 5aza-mediated cardiomyocyte differentiation.
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Figure. 3.5. GSK3β is involved in 5aza-induced differentiation of CSCs to cardiomyocytes. (A)
Sca-1+ cells from WT mice were treated with 5aza as in Figure 3.1A and incubated with or
without SB216763 at 10 µM for the first 3 days. The mRNA expression of MYH6 and cTnT was
analyzed by RT- PCR analysis. (B) Sca-1+ cells from WT and Arrb2-KO mice were treated with
5aza as in Figure 3.1A. The expression of total and phosphorylated Akt (p-Akt), total and pGSK3β were analyzed by western blot. (C) Quantification of p-Akt levels shown in B. protein
level were normalized to AKT. (D) Quantification of p-GSK3β levels shown in B. protein level
were normalized to GSK3β. Data are mean ± SEM of four experiments. *P < 0.05; **P < 0.01.

5aza Promotes Sca-1+ cell Transition to Cardiomyocytes through an Arrb2/miR-155/GSK3
Pathway
To analyze the signaling pathways involved in myocardiac differentiation, we examined
the effect of Arrb2 on changes in GSK3β expression. 5aza inhibited the phosphorylation of
GSK3β. However, Arrb2-KO in Sca-1+ cells promoted phosphorylation of GSK3β and inhibited
its activity (Fig. 3.5B and D). Thus, Arrb2 participated in 5aza-induced CSC transition to
cardiomyocytes by promoting GSK3β activation. Akt is a well-known upstream inhibitor of
GSK3β activation. To exclude the function of Akt on GSK3β activation, we detected changes in
Akt activity. Phosphorylation of Akt was increased in 5aza-treated CSCs, and Arrb2-KO in Sca1+ cells inhibited 5aza-induced activation of Akt. The mortality of the I/R model in mice is about
40%. Because all the change rules are in contrast to the changes in AKT as the inhibitor to
GSK3β (Fig. 3.5B and C), we concluded that Arrb2 promoted the activation of GSK3β by
inhibiting miR-155 but not Akt.
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Arrb2/miR-155/GSK3β Pathway in CSC-mediated Cardiac Repair
To determine the role of the Arrb2/miR-155/GSK3β pathway in CSC-mediated cardiac
repair in vivo, we injected stem cells from WT and KO mice into the hearts of mice with
myocardial infarction. After 2 weeks, immunofluorescence assay revealed that the injected Sca1+ cells could differentiate into myocardial cells (Fig. 3.6A). Arrb2 protein was expressed in
Arrb2-KO mice after transfer of Sca-1+ CSCs from WT mice (Fig. 3.6B), which suggests that
the transplanted cells could survive in the mice with myocardial infarction. Furthermore, in KO
mice, the low protein level of Arrb2 caused low phosphorylation of Akt and high
phosphorylation of GSK3β, which agrees with in vitro results (Fig. 3.6B).

Figure 3.6. Arrb2/miR-155/GSK3β pathway is important in CSC-mediated cardiac repair.
Isolated 2×105 Sca-1+ cells from WT or Arrb2-KO mice were injected immediately into
infarcted and border zones of the mouse heart after myocardial infarction (MI). Hearts were then
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reperfused for 1 hr. After 2 weeks, 2-mm sections of hearts near the mid-ventricles were
collected. (A) Fluorescence microscopy of hearts for WT mice with MI injected with WT Sca-1+
cells and stained with cTnT. Red shows cardiomyocytes; green shows injected Sca-1+ cells; blue
shows DAPI- stained cell nuclei; scale bar, 40 µm; n = 6. (B) Western blot analysis of the
expression of Arrb2, total Akt and p-Akt, and total and p-GSK3β. GADPH was a loading
control. The column shows the quantification of the protein expression. Protein levels were
normalized to GAPDH or total protein; n = 3; *P < 0.05; **P < 0.01 versus WT.

Cardiac function analysis showed that myocardial infarction (injected with medium)
impaired cardiac function significantly as compared with the sham control (P < 0.01 versus
sham), and trans plantation of Sca-1+ cells from WT mice could protect cardiac function,
including ejection fraction, cardiac output, stroke volume and Vmax (P < 0.01 versus WT mice
injected with medium). However, cardiac function measures did not differ with transplantation of
Sca-1+ cells from Arrb2-KO and from WT mice, except for impaired indexes of arterial
elastance and Tau-weiss (P < 0.01 versus WT mice injected with medium; P < 0.01 versus WT
mice injected with WT Sca-1+ CSCs) (Table 3.1).
To exclude the affection of background expression of Arrb2 in WT mice, we transplanted
WT or Arrb2 KO Sca-1+ CSCs to Arrb2 KO mice with myocardial infarction, high level of
Arrb2 equal to better performance of cardiac function, including ejection fraction, cardiac output,
stroke volume and Vmax (Table 3.2), which verified the important role of Arrb2 in heart repair.
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Table 3 Effects of Sca-1+ CSCs on the cardiac function of wild-type mice with myocardial infarction

*P < 0.01 versus sham. †P < 0.01 versus WT mice injected with medium. ‡P < 0.01 versus WT mice injected with WT type
Sca-1+ cells. Data are mean ` SEM of six experiments. HR: heart rate; EF: ejection fraction; LVDP = ESP-EDP; ESP: endsystolic pressure; EDP: end-diastolic pressure; CO: cardiac output; E(a): arterial elastance.
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Table 4 Effects of Sca-1+ CSCs on the cardiac function of Arrb2-KO mice with myocardial infarction

*P < 0.05 compared with wild-type sca-1 injection. Data are mean ± SEM of six
experiments. EF: ejection fraction; CO: cardiac output.
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Discussion
Recently, both experimental and clinical findings have revealed that the heart can replace
cardiomyocytes throughout life, but this response is inadequate to compensate for major injuries
such as myocardial infarction (18). So resident CSCs could be stimulated to differentiate into
cardiomyocytes. Resident Sca-1+ CSCs, existing in humans and mice (4, 19), have therapeutic
functions on the heart because of their differentiation potential. We used the 5aza-induced
differentiation model in vitro, and showed that Arrb2 could promote the differentiation of Sca-1+
cells to cardiomyocytes, which suggested an important role of Arrb2 in Sca-1+ cell transition and
promoted us to explore the mechanisms of Arrb2 mediated Sca-1+ CSCs transition to
cardiomyocyte. As 5-Azacytidine can induce gene expression through demethylation (20), we
deduced that 5-Azacytidine regulated β-arrestin2 expression by decreasing the degree of
methylation of the β-arrestin2 gene or other genes. In this study, we focused on the pathway
regulated by β-arrestin2, but how 5-Azacytidine regulated β-arrestin2 expression still needs
further research.
MiR-155, a well-known multifunctional miRNA, was indicated to play a crucial role in
various physiological and pathological processes such as hematopoietic lineage differentiation,
immunity, inflammation, cancer, and cardiovascular diseases (21), but its role in CSC
differentiation is not clear. Our results showed that miR-155, the predicted regulator of Arrb2,
inhibited the 5aza-induced differentiation of Sca-1+ cells to cardiomyocytes and was regulated
by Arrb2. So miR-155 might locate downstream of Arrb2. However, dual luciferase reporter
assay showed that miR-155 also inhibited the expression of Arrb2. We suggest a loop pathway
between miR-155 and Arrb2, which explains the mechanism for its participation in regulating
cardiovascular diseases.
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As the downstream of Arrb2 and the target of miR-155, GSK3β promoted the 5azainduced murine Sca-1+ cell differentiation. This result is the same as its role in cardiomyocyte
differentiation of murine bone marrow-derived mesenchymal stem cells (22). Although GSK3β
is regulate by Arrb2 in cell apoptosis and target by miR-155 in T-cell proliferation has been
reported (5, 23), we analyzed the relationship among the three factors, and explored the
important roles of Arrb2/miR-155/GSK3β pathway in cardiomyocyte differentiation of Sca-1+
cell. Furthermore, we verified that AKT and GSK3β are down- stream of β-arresin2. However,
GSK3β activity was not affected by Akt phosphorylation as usual. As the protected function of
GSK3β to regional myocardial ischemia/reperfusion injury has been verified (24, 25), so the
Arrb2/miR-155/GSK3β pathway might be a new tar- get for CSC-mediated cardiac repair.
We transplanted CSCs from WT or Arrb2 KO mice into mice with myocardial infarction to
analyze the function of Arrb2 in CSC-participating cardiac repair. In WT infarcted mice, Arrb2–
KO CSCs showed the same protective functions, except for arterial elastance perhaps because
the background of Arrb2 in WT infarcted mice affected its actual role. Otherwise, it might be
caused by the interference of the adrenal-dependent neurohormonal mechanisms. β-arrestins
(including Arrb1and Arrb2) have been shown to activate epidermal growth factor receptor by
eliciting a G-protein–independent signals in vitro, so they might be beneficial for the failing
heart. However, with regard to the heart, Arrb1 preferred to perform a G-protein dependent
function, and regulates the majority of cardiovascular G protein-coupled receptors, especially
adrenal and central sympathetic nervous system a2ARs, to perform a negative impact on postmyocardial infarction heart failure via cardiac and adrenal-dependent neurohormonal
mechanisms (26). Arrb2 has the same effect as Arrb1 on cardiac b1ARs and Adrenal a2AR
internalization (27). So it is not strange that Arrb2 also protect the heart from damage. As

84

Arrb20s role was affected by adrenal-dependent neurohormonal mechanisms, only development
of tissue-specific KO mice can provide definitive answers to this important question. However,
low Arrb2 level agreed with decreased phosphorylation of AKT and increased phosphorylation
of GSK3β, findings also found in vitro. Furthermore, we transplanted WT or Arrb2 KO Sca-1+
CSCs to Arrb2 KO mice with myocardial infarction, high level of Arrb2 equal to better
performance of cardiac function, verified the vital function of Arrb2 in cardiac repair. The
Arrb2/miR-155/GSK3β pathway may be a new mechanism with implications for treatment of
heart disease.
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Abstract
Emerging evidence implied that chronic stress has been exerting detrimental impact on
immune system functions in both humans and animals. Toll-like receptors (TLRs) have been
shown to play an essential role in modulating immune responses and cell survival. We have
recently shown that TLR9 deficiency protects against lymphocyte apoptosis induced by chronic
stress. However, the exact role of TLR9 in stress-mediated change of macrophage function
remains unclear. The results of the current study showed that when BALB/c mice were treated
with restraint stress (12 h daily for 2 days), the number of macrophages recruited to the
peritoneal cavity was obviously increased. Results also demonstrated that the sustained effects of
stress elevated cytokine IL-1β, TNF-α and IL-10 production yet diminished IFN-γ production
from macrophage, which led to apoptotic cell death. However, TLR9 deficiency prevented the
chronic stress-mediated accumulation of macrophages. In addition, knocking out TLR9
significantly abolished the chronic stress-induced imbalance of cytokine levels and apoptosis in
macrophage. TLR9 deficiency was also found to reverse elevation of plasma IL-1β, IL-10 and
IL-17 levels and decrease of plasma IFN-γ level under the condition of chronic stress. These
results indicated that TLR9-mediated macrophage responses were required for chronic stressinduced immunosuppression. Further exploration showed that TLR9 deficiency prevented the
increment of p38 MAPK phosphorylation and reduction of Akt/Gsk-3β phosphorylation; TLR9
deficiency also attenuated the release of mitochondrial cytochrome c into cytoplasm, caused
upregulation of Bcl-2/Bax protein ratio, downregulation of cleavage of caspase-3 and PARP, as
well as decreased TUNEL-positive cells in macrophage of stressed mice. Collectively, our
studies demonstrated that deficiency of TLR9 maintained macrophage function by modulating
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92

macrophage

apoptosis,

thus

preventing

Introduction
Experimental studies and clinical observations have indicated that stress serves as an
important risk factor in the etiology of infectious and autoimmune diseases (1, 2). Both acute and
chronic stress has been found to have dramatic impacts on the immunological parameters in both
humans and animals. Data suggested a positive effect of acute stress on the immune system,
while chronic stress frequently leads to immunosuppression (3). These effects at least partly
depend on the function of and apoptotic cell death of immune cells. Numerous studies have
revealed that chronic stress leads to a decrease of thymocytes and splenocytes by a mechanism
associated with stress-induced lymphocyte apoptosis (4,5). As one of the most important immune
cells, macrophages might express inducible nitric oxide synthase (iNOS), H2O2, tumor necrosis
factor (TNF)-α and interleukin (IL)-1, which participate in the macrophage-induced suppression
of immune responses (6, 7). However, it remains unknown whether macrophages are involved
with the immune suppression due to chronic stress. Recent study reveals that stressful life events
are associated with altered levels of macrophages in rat models of prostate and breast cancers(8),
we hypothesize that chronic stress plays immunosuppressive function partially by inducing
macrophage responses. Here, we employed the physical restraint stress mouse model to examine
the relationship between chronic stress and macrophage, and to explore the effect of chronic
stress on macrophage apoptosis and the possible molecular mechanism.
Macrophages play important roles in regulating immunity by virtue of their ability to
secrete a multitude of proinflammatory cytokines and chemokines. Many studies have shown
that toll-like receptors (TLRs) modulate the activation of macrophages by pathogens. Among the
subsets of TLRs, several pattern recognition receptors have previously been implicated in the
chronic stress-induced immune response, including TLR2 and TLR4, as well as the downstream
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the phosphoinositide 3-kinase (PI3K)/Akt signaling (5, 9). Previous studies have indicated an
involvement of TLR9 in the development of innate immune responses, but the precise role of
TLR9 and the underlying mechanisms in the macrophage response after chronic stress exposure
is still poorly documented. Recent studies reported that stressed mice showed increased intestinal
permeability which resulted in bacterial translocation to the peritoneal cavity (10). These
peritoneal bacteria are a major source of CpG DNA, which can trigger the activation of
macrophage TLR9 and cause immune response (11). Recent studies from us and others have
revealed that activation of TLR9 signaling triggers activation of pro-apoptotic signaling
pathways, and cause cell apoptosis in various system (11–13).
TLR9 stimulation activates PI3K/Akt and mitogen-activated protein kinase (MAPK)
signaling pathway (14). Akt is an important cellular factor which exerts critical roles in
regulating many cellular functions, such as cellular activation, inflammatory response, and
apoptosis (15). GSK-3β is a constitutively active enzyme that is inactivated by Akt which
regulates cell survival and apoptosis (16). MAPKs are associated with some important aspects of
immune responses (17). Among MAPK families, p38 MAPK is easily activated by stress signals
(18). Earlier studies established that activation of p38 MAPK and down-regulation of Akt kinase
led to leucocytes apoptosis by the disruption of Bcl-2, caspase activation and subsequent
apoptotic features (19).
A distinctive feature of activated macrophages is their capacity to rapidly generate TNF-α
in response to diverse stimuli. In addition to producing TNF-α, activated macrophages secrete
the cytokine IL-10 which contributes to the down-regulation of IFN-γ and consequently, in the
apoptosis process of macrophage, highlighting the importance of macrophage in innate and
adaptive immune responses (20). This report investigates mechanisms by which TLR9 inhibition
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suppresses chronic stress-induced imbalance of cytokines production. We demonstrated that
TNF-α, IL-1βand IL-10 production, as well as p38 activation, cleaved caspase-3 and cleaved
poly ADP-ribose polymerase (PARP) induced by chronic stress were impaired in macrophages
from TLR9-deficient mice. We also showed that TLR9 deficiency did restore chronic stressimpaired IFN-γ production, Akt/GSK-3β phosphorylation and Bcl-2/Bax ratio in macrophage.
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Materials and Methods
Experimental Animals
Breeding pairs of TLR9 knockout (not a functional knockout) mice on a BALB/c
background were kindly provided by Dr. Shizuo Akira (Osaka University, Osaka, Japan) via Dr.
Dennis Klinman (National Cancer Institute, Frederick, MD). Wild type BALB/c male mice were
purchased from the Harlan (Indianapolis, Indiana) and all mice were kept in the Division of
Laboratory Animal Resources at East Tennessee State University (ETSU), a facility accredited
by the Association for the Assessment and Accreditation of Laboratory Animal Care
(AAALAC). All animals were maintained in a specific pathogen-free room under controlled
conditions at the room temperature (23 ± 1℃) with a 12-h light-dark cycle. All experiments
were adhered to the animal use protocol approved by the ETSU Committee on Animal Care.

Experimental Model of Restraint Stress
All mice (male, weight 23~25g) were healthy and six to eight-week-old. The protocol used
to establish chronic physical restraint model was proved to be effective in our laboratory as well
as others (21). Briefly, wild type mice and TLR knockout mice were randomly divided into 2
groups, 7 in each group, respectively. Each individual mouse of stress group was placed in a 50ml polypropylene conical centrifuge tube (Corning, NY). The tubes were arranged with multiple
punctures for ventilation. Mice were restricted horizontally in the tubes for 12 h (from21:00 to
next day 9:00) followed by a 12 h rest (from 9:00 to 21:00). The stressed mice were kept next to
each other. The stressed mice were provided with food and water during the rest period in an
ordinary cage. Food and water were provided to control littermates in their original cage only
during the 12 h rest. The cages were transparent, well-ventilated and only contained food, water
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and bedding materials during the rest period. Observations in our laboratory showed that during
restraint, the mice did not suffer from any physical suppression or pain. After 2 cycles, mice
were humanely killed by cervical dislocation for the subsequent experiments.

Isolation of Peritoneal Macrophages
After the two cycles of stress finished, mice were humanely killed by cervical dislocation,
and peritoneal macrophages were collecting by injecting 5 ml of phosphate-buffered saline
(PBS) into the peritoneal cavity. The cell suspension was cultured with RPMI-1640 containing
10% fetal bovine serum (FBS) for 60 min at 37°C in to allow the macrophages to adhere as
described by Mantovani (22). After being washed in PBS, the non-adherent cells were removed.
The purity of macrophages was >95%.

Determination of Apoptosis by TUNEL Assay
TUNEL assay was performed according to our previous study (23). Apoptotic nuclear
DNA fragments were investigated using the In Situ Cell Death Detection kit (Roche Diagnostic,
Indianapolis, IN). Briefly, macrophages (5 × 105 cells) from wild type and TLR9 knockout mice
were fixed in 4% formaldehyde/PBS for 20 min at 37°C，permeabilized in 0.1% sodium citrate
solution containing 0.1% Triton X-100, for 10 min, after that, the sections were incubated with
50 µL of TUNEL reaction mixture for 60 min at 37°C. After convert-AP incubation, 50 µL of
substrate solution was placed on the slices. Finally, sections were conterstained with
haematoxylin. Slices were observed under a light microscope using a 40× objective.
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Western Blot Analysis
Western blotting was performed as described previously (1, 20). Briefly, the cellular
proteins were fractionated by 10% SDS-PAGE gel and electroblotted onto Hybond ECL
membranes (Amersham Pharmacia, NJ). After being blocked with nonfat milk, the membranes
were blotted overnight at 4°C with following primary antibody (anti-TLR9, anti-phospho-p38,
anti-p38, anti-phospho-Akt, anti-Akt, anti-cleaved-caspase-3, anti-caspase-3, anti-PARP, antiBcl-2, anti-Bax, anti-phospho-GSK-3β, anti- GSK-3β, anti-GAPDH (Cell Signaling Technology,
Beverly, MA) (20). Next day, after incubation with HRP-conjugated secondary antibodies (Cell
Signaling Technology, Inc.), membranes were then developed with the Super Signal West Dura
Extended Duration substrate (Pierce Biotechnology, Rockford, IL). The bands were quantified
by densitometry using a Bio-Image Analysis System (Bio-Rad).

Enzyme Linked Immunosorbent Assay (ELISA) for Cytokines
Equal amounts of peritoneal macrophages (5×105 cells/ mL) were planted in 96-well
plates. The supernatants were harvested after 24 h of incubation. The concentration of cytokines
in the supernatants was detected by ELISA kits (R&D Systems, Minneapolis, MN) according to
our previous studies (5).

Statistical Analysis
Data were expressed as mean ± S.E.M. Statistical analysis were performed using one-way
analysis of variance (ANOVA) followed by Bonferroni tests to examine whether differences
among groups existed. A P value < 0.05 was accepted as significant.
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Results
TLR9 is Required for Chronic Stress-induced Macrophages Accumulation
Recent evidence showed that TLR9 is largely expressed on macrophages, however, the
exact role of TLR9 in modulating macrophage function is not known yet (24). Data suggests that
chronic stress increases TLR9 expression in peritoneal macrophage (Fig 4.1A). We therefore
asked whether TLR9 is involved in stress-mediated changes of macrophage function. Since
macrophages in peritoneal cavity of chronic stress-induced mice, irrespective of their location,
can significantly contribute to inflammation and immune response by producing cytokines and
free oxygen radicals (25) (26), it is important to assess the total number of macrophages
accumulated in peritoneal cavity. Therefore, we decided to examine the pattern of total
macrophages increase after stress treatment in the peritoneal cavity of TLR9 knockout and wild
type mice. We observed a robust accumulation of macrophages in peritoneal cavity 2 days after
stress challenge, representing a > 2-fold increase over baseline number of cells; no significant
change in number of peritoneal macrophages was observed after stress challenge compared with
that in control group in TLR 9 knockout mice (Fig 4.1B). Therefore, TLR9 knockout mice lose
their sensitivity to chronic stress-induced accumulation of macrophages, supporting a critical role
of TLR9 in stress-induced immune response.
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Figure 4.1. A deficiency of TLR9 blocks chronic stress-induced accumulation of macrophages in
peritoneal cavity. TLR9 knockout mice or wild type BALB/c mice aged 6 to 8 weeks were
subjected to a 12 h physical restraint daily. After 2 d stress, mice were sacrificed by cervical
dislocation, and the peritoneal macrophages were harvested and the counts were performed. For
TLR9 protein expression evaluating, the macrophages were harvested and cultured for 24 hours.
The expression of TLR9 was analyzed by Western blot. Means and SEs were calculated from 7
mice per group. * p < 0.05, ** p< 0.01 compared with indicated groups.
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Macrophages from TLR9 Knockout Mice Display Impaired Changes of Chronic Stress-induced
Cytokine Levels
In response to a large range of stimulation, macrophages secrete powerful biological
substances, such as TNF-αand interleukins. This secretion results in inflammation. To investigate
whether the diminished accumulation observed in the TLR9 knockout mice was secondary to
altered macrophage function, we have detected generation of major pro-inflammatory cytokines
by macrophages. Wild type and TLR9 knockout mice were subjected to stress as described
previously, peritoneal macrophages were harvested and cultured for 24 hours. Our data showed
that IL-1β, TNF-α, IL-10 were significantly overproduced in supernatants of macrophages of
stressed wild type mice, increasing by 2.2-, 3.1- and 1.8-fold, compared to that of control wild
type mice, respectively. However, IL-1β, TNF-α, IL-10 levels of stressed TLR9 knockout mice
displayed no distinctive change compared to control TLR9 knockout mice and (Fig 4.2A, 4.2C
and 4.2D). Chronic stress significantly inhibited IFN-γ production in supernatant of macrophages
from stressed wild type mice by 2.5-fold than that from control wild type mice, but no change in
IFN-γ expression level in supernatant of macrophages was observed after chronic stress
challenge in TLR9 knockout mice (Fig 4.2B).
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Figure 4.2. A deficiency of TLR9 decreases chronic stress-induced changes of pro-inflammatory
cytokine levels by macrophages. TLR9 knockout mice or wild type BALB/c mice aged 6 to 8
weeks were subjected to a 12 h physical restraint daily. After 2 d stress, mice were sacrificed by
cervical dislocation, and the macrophages were harvested, purified and cultured (5 × 105
cells/well) on culture plates for 24 hours. IL-1β, TNF-α, IL-10 and IFN-γ levels were measured
in supernatants of macrophages by ELISA kit. Means and SEs were calculated from 7 mice per
group. * p < 0.05, ** p< 0.01 compared with indicated groups.
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TLR9 Deficiency Blocks Chronic Stress-induced Changes of Pro-inflammatory Cytokines in
Serum
It is known that excessive production of plasma proinflammatory cytokines in response to
chronic stress can promote the development of immune suppression. We next assessed the
expression of IL-1β, IL-10, IL-17 and IFN-γ in the serum of wild type and TLR9 knockout mice
challenged with chronic stress. Our data showed that expression level of IL-1β, IL-10, IL-17 in
the serum of stressed wild type mice increased by 3.3-, 2.9- and 2.8-fold, compared to that of
control wild type mice, respectively. However, the expression level of IL-1β, IL-10, IL-17 did
not differ between the control TLR9 knockout mice and stressed TLR9 knockout mice (Fig 4.3A,
4.3B and 4.3C). Chronic stress significantly inhibited IFN-γ production in the serum from
stressed wild type mice by 2.1-fold than serum from control wild type mice, but chronic stress
failed to induce the change in TLR9 kncokout mice (Fig 4.3D).

TLR9 Deficiency Blocks Chronic Stress-induced Macrophage Apoptosis
Our recent study showed that chronic stress induces lympocyte apoptosis (2). We also
reported that chronic stress promotes cell apoptosis through TLR9 (12). To determine whether
TLR9 is associated with stress-induced macrophages apoptosis, wild type and TLR9 knockout
mice were subjected to stress as described previously, peritoneal macrophages were then
harvested and cultured for 24 hours and TUNEL assay was performed to detect cell apoptosis.
We found that a large amount of wild type macrophages were undergoing apoptosis after
restraint stress, whereas only a few apoptotic cells were detected in the TLR9 deficient
macrophages following stress challenge (Fig 4.4). Therefore, stress-induced macrophage
apoptosis requires TLR9.
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Figure 4.3. A deficiency of TLR9 suppressed change of cytokine levels caused by chronic stress.
TLR9 knockout mice or wild type BALB/c mice aged 6 to 8 weeks were subjected to a 12 h
physical restraint daily. After 2 d stress, mice were sacrificed by cervical dislocation, and the
serum were harvested and the levels of IL-1β, IL-10, IL-17 and IFN-γ in serum were examined
by ELISA kit. Means and SEs were calculated from 7 mice per group.
compared with indicated groups.
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*

p < 0.05,

**

p < 0.01

Figure 4.4. A deficiency of TLR9 is resistant to stress-induced macrophage apoptosis. TLR9
knockout mice or wild type BALB/c mice aged 6 to 8 weeks were subjected to a 12 h physical
restraint daily. After 2 d stress, mice were sacrificed by cervical dislocation, and the
macrophages were harvested, purified and cultured (5 × 105 cells/well) on culture plates for 24
hours. Apoptotic cells (dark brown color cells) were determined by TUNEL assay. Photographs
of representative TUNEL-stained cells are shown at the top. Magnification 200×. The bar graph
shows the percentage of apoptotic cells. Means and SEs were calculated from 7 mice per group. *
p < 0.05, ** p < 0.01 compared with indicated groups.
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TLR9 Deficiency Attenuates Stress-induced Activation of Caspase-3 and PARP and Alteration
of Bcl-2/Bax Ratio
The levels of major apoptosis-related proteins were detected to further assess the
mechanisms underlying cellular changes observed in mice after stress challenge. We found that
the levels of cleaved caspase-3 and cleaved PARP, two well-known characteristics of apoptosis,
were remarkably increased in macrophages of wild type mice following stress treatment,
whereas the increases of cleaved caspase-3 and cleaved PARP were attenuated markedly in
TLR9 deficient macrophages (Fig 4.5A). As protein expressions of Bcl-2 and Bax are involved
in the chronic stress-induced apoptotic pathway (27), we examined the ratio of Bcl-2 and Bax in
macrophages to elucidate the mechanism of stress-induced apoptosis. Stress challenge markedly
decreased the ratio of Bcl-2/Bax in wild type macrophages; moreover, the expressions of Bcl-2
and Bax in the macrophages were not altered in TLR9 deficient mice. Our data suggested that
Bcl-2 family participate in TLR9-mediated macrophage signaling after stress treatment (Fig
4.5B).
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Figure 4.5. TLR9 deficiency inhibits stress-induced change in caspase-3 and PARP activation
and ratio of Bcl-2/Bax. TLR9 knockout mice or wild type BALB/c mice aged 6 to 8 weeks were
subjected to a 12 h physical restraint daily. After 2 d stress, mice were sacrificed by cervical
dislocation, and the macrophages were harvested, purified and cultured (5 × 105 cells/well) on
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culture plates for 24 hours. The expression of cleaved caspase-3 and cleaved PARP (A), and Bcl2/Bax (B) was analyzed by Western blot. Means and SEs were calculated from 7 mice per group.
*

p < 0.05, ** p < 0.01 compared with indicated groups.

TLR9 Deficiency Blocks Chronic Stress-induced Changes of Apoptosis Related Pathways
Accumulating evidence indicates that p38 MAPK participates as a modulator in Bcl2/Bax-mediated apoptosis in neuroblastoma cells (28, 29). It also has been demonstrated that
activated Akt alters the ratio of Bcl-2 and Bax and exhibits an anti-apoptotic role in various cells
(30). Additionally, recent studies have revealed cross-talk between TLR signaling and the
Akt/GSK-3β or p38 MAPK signaling pathway (13, 31). To examine whether chronic stress
activates p38 MAPK and Akt/GSK-3β signaling in TLR9-mediated signaling, the levels of
phosphorylated p38 (phospho-p38), phospho-Akt and phospho-GSK-3β in macrophages
following stress treatment were examined by western blot analysis. The results of the present
study confirmed that chronic stress promoted p38 phosphorylation in wild type macrophage.
Moreover, stress-induced p38 MAPK activation was reversed in TLR9 knockout macrophages
suggesting that stress markedly increases the level of phospho-p38 through TLR9 (Fig 4.6). We
also found that the increasing levels of phospho-Akt and phospho-GSK-3β were significantly
abolished by chronic stress in wild type macrophages but not in TLR9 deficient macrophages,
demonstrating that chronic stress decreases the activation of phospho-Akt/phospho-GSK-3β
signaling in a TLR9-dependent manner (Fig 4.6).
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Figure 4.6. TLR9 deficiency attenuates chronic stress-induced changes of apoptosis related
pathways. TLR9 knockout mice or wild type BALB/c mice aged 6 to 8 weeks were subjected to
a 12 h physical restraint daily. After 2 d stress, mice were sacrificed by cervical dislocation, and
the macrophages were harvested, purified and cultured (5 × 105 cells/well) on culture plates for
24 hours. The expression of total and phospho-p38, total and phospho-Akt, total and phosphoGSK-3β were analyzed by Western blot. Means and SEs were calculated from 7 mice per group.
*

p < 0.05, ** p< 0.01 compared with indicated groups.
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Discussion
The knowledge on pattern recognition receptors (PRRs) recognition and activation of an
efficient immune response against chronic stress has progressively increased, mainly in regards
to TLR2, TLR4 (5, 27). Several lines of evidence suggest that TLR9 seems to participate in
chronic stress-mediated immune suppression, however, the involvement of TLR9 in functional
change of macrophages following chronic stress treatment has not yet been addressed. Our data
presented herein clearly revealed that chronic stress might act through TLR9 to generate
macrophage inflammation and apoptosis, further supporting that TLR9 plays a role in immune
response.
In response to multiple waves of pathogenic stimuli, inflammatory mediators including
TNF-α, IFN-γ, IL-1β, IL-6 and IL-10 may be liberated by macrophages. These molecules with
diverse physiological effects might play critical roles in the recruitment and apoptosis of
macrophages. Indeed, in the present study, we showed that chronic stress induced series
inflammatory response characterized by recruitment of macrophages into the peritoneum;
generation of pro-inflammatory mediators from macrophages, such as IL-1β and TNF-α and
induction of apoptosis. Interestingly, TLR9 deficiency markedly diminished these inflammatory
responses induced by chronic stress.
Our previous study indicates that chronic stress causes an imbalance in the Th1 and Th2
responses (32). Increase of IL-1βand TNF-αsecretion in blood and brain turns out to be a
common feature of diverse models of stress (33), whereas the decrease of other cytokines like
IFN-γ and IL-10 seems to be more controversial (34–36). IL-17, an important cytokine produced
by Th17 cells, is able to indirectly induce the recruitment of macrophages and neutrophils during
inflammation (37). In fact we showed in this study that chronic stress could induce a dramatic
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increase of IL-1β, IL-10 and IL-17 production and a significant decrease of IFN-γ synthesis. In
contrast, the production of these cytokines was almost unaffected in TLR9 deficient mice under
chronic stress influence. These results corroborate a previous report showing that malaria in
TLR9 knockout mice significantly diminishes changes of Th1 and Th2 cytokines as compared to
control wild type mice (38), indicating that chronic stress leads to immune suppression in a
TLR9-dependent manner.
We next attempted to investigate the mechanistic pathway by which TLR9 modulates
immune responses. During the process of apoptosis several targets have been identified as
characteristic of cell death, including the potential decreases in mitochondrial membrane (25).
Apoptotic stimulation causes the change in mitochondrial membrane potential and the release of
cytochrome C into the cytoplasm, activating caspase-9, triggering activation of other caspase
members, including caspase-7 and caspase-3, to initiate a caspase cascade, which leads to
apoptosis (39, 40). Furthermore, PARP acts as the main cleavage targets of caspase-3 (41). For
these reason, we detected the expression of cleaved-caspase-3 and cleaved-PARP. In our current
study, we demonstrated that chronic stress dramatically upregulated cleavage of caspase-3 and
PARP in wild type macrophages. This agrees with our previous report on chronic stress-induced
apoptosis accompanied by caspase-3 activation in splenocytes (27). We also found that the
elevated activation of caspase-3 as well as PAPR was significantly blocked to almost control
level in TLR9 deficient macrophages. In addition, apoptosis is commonly associated with an
imbalance between pro- and anti-apoptotic members of the Bcl-2 family. In the current study, the
ratio of Bcl-2/Bax was markedly reduced in chronic stress-induced macrophage, indicating that
cells were undergoing apoptosis, however, TLR9 deficiency elevated the Bcl-2/Bax ratio
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remarkably in macrophage, further confirming that TLR9-deficient macrophage was resistant to
chronic stress-induced apoptosis.
Accumulating evidence suggests that p38 MAPK and Akt signaling pathways acts to
regulate the cell cycle progression and proliferation (42, 43). The data of current study indicated
that the p38 signaling pathway was significantly activated by chronic stress treatment in wild
type macrophages, indicating that p38 was involved in stress-induced macrophage apoptosis. In
contract, stress-induced p38 activation was suppressed in TLR9 knockout macrophages,
suggesting that stress promoted p38 phosphorylation through TLR9. Consistently, a recent study
showed that activation of p38 MAPK signaling pathway by morphine induced apoptosis in a
TLR9 dependent manner (31). As recent evidence implicates, there is a cross-talk between TLR
signaling and the Akt/GSK-3β signaling pathway. In previous studies we documented that TLR2
was required for chronic stress-induced apoptosis via PI3K/Akt/GSK-3β signaling cascade in
lymphocytes (9). Additionally, the PI3K/Akt signaling cascade may participate in TLR4mediated immune responses as an endogenous negative feedback regulator (5). Considering that
Akt/GSK-3β has an important role on immune cells activation in a TLR dependent manner, we
then addressed the question of whether this signaling pathway was associated with chronic
stress-induced macrophage apoptosis. As expected, no phosphorylation was detected in
macrophages when wild type mice were subjected to chronic stress. In contract, phosphorylation
of Akt and GSK-3β was restored to the normal level in TLR9 deficient macrophages, suggesting
that in TLR9 deficient mice, the higher level of phosphor-Akt and phosphor-GSK-3β prevents
macrophages from stress-induced inflammation and apoptosis. Collectively, our data implicates
that TLR9 participates in chronic stress-induced immune response via mediating apoptosisrelated signaling pathways and proteins.
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In summary, our data demonstrated that the chronic stress plays immunosuppressive
function partially by inducing macrophage responses and was characterized by a vigorous TLR
9-mediated accumulation of macrophages and release of cytokine, resulting in alteration of
macrophage cell signaling and immunosuppression. Theses cytokines might further participate in
the apoptosis of macrophages. Bcl-2 family and caspase-3; p38 MAPK and Akt/GSK-3β
signaling take part in TLR9-mediated chronic stress-induced apoptosis in macrophage.
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CHAPTER 5
SUMMARY
Major findings of our research were:
1.β-arrestin2 overexpression promoted survival in CLP-induced septic shock.
2.Cardiac dysfunction induced by CLP was dampened in β-arrestin2 overexpression mice.
3.The activation of gp130 and p38 was inhibited in β-arrestin2 TG mice in
CLP-induced heart injury.
4.β-arrestin2 knockout mice were more vulnerable to CLP-induced cardiac dysfunction
than wide-type and β-arrestin2 overexpression mice.
5.End diastolic volume was preserved in β-arrestin2 overexpression mice in
hemodynamic analysis followed by CLP.
6.Pre-activation of STAT3 was involved in the protective mechanism of β-arrestin2
overexpression mice after CLP.
7.Cardiomyocyte apoptosis was decreased in β-arrestin2 overexpression mice in
CLP-induced sepsis.
8.Serum IL-6 level was not affected by β-arrestin2 expression in severe sepsis.
9.Cardiac β-arrestin2 expression might up-regulate IL-6/IL-6R/gp130/STAT3 anti-apoptotic
signaling in a p38 involved manner.
10.MiR-155 was inhibited by β-arrestin2 in Cardiac Stem Cell differentiation.
11.5’-azacytizine-induced Sca-1+ CSC differentiation was negatively regulated by miR-155.
12.Luciferase report study showed β-arrestin2 activation could be inhibited by miR-155.
13.Luciferase report study showed GSK-3β activation could also be inhibited by miR-155.
14.The activity of GSK-3β was inhibited in β-arrestin2 knockout cells
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15.β-arrestin2 but not Akt played a key role in regulation of GSK-3β activation
16.The function of Cardiac Stem Cell from β-arrestin2 knockout mice was intact.
17.β-arrestin2/miR-155/ GSK3β pathway was critical for 5’-azacytizine-induced
Sca-1+ CSC differentiation
18.The amount of macrophages was increased in peritoneal fluid of BALB/c mice in restraint
stress.
19.TNF-α, IL-1β, and IL-10 levels were increased in the restraint stress model.
20.IFN- γ level was decreased in restraint stress.
21.Macrophage apoptosis was found in restraint stress model.
22.Cytokine levels were reversed in TLR9 deficient mice in chronic stress.
23.Cytokine and macrophages response were mediated by TLR9 in Chronic Stress.
24.TLR9 deficiency decreased p38 activation in chronic stress.
25.Akt and GSK-3β phosphorylation was increased in TLR9 deficiency mice in chronic
stress.
26.Mitochondrial cytochrome c release was inhibited by TLR9 deficiency mice in
chronic stress.
27.Bcl-2/Bax protein ratio were increased in TLR9 deficiency mice in chronic stress.
28.Cleavage of caspase-3 and PARP were down-regulated by TLR9 deficiency in chronic
Stress.
29.Macrophage apoptosis was inhibited by TLR9 deficiency in restraint stress induced
chronic stress.
30.Immunosuppression was prevented by TLR9 deficiency in restraint-stressed mice.
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These results showed the protective effect of β-arrestin2 expression in multiple
inflammatory conditions specifically in sepsis, ischemic heart injury and suggested the role of
TLR-9 in restraint stress.
β-arrestin2 overexpression was beneficial to septic mice by maintaining the preload and
contractility of the heart. β-arrestin2 was a signal transducer in the IL-6 signaling pathway, and
the downstream effectors of β-arrestin2 could be membrane-bound IL-6 receptor gp130 and proapoptosis effector p38. β-arrestin2 could also promote residential cardio stem cell differentiation
by miR-155 inhibition and GSK-3β activation. An earlier report from our lab showed TLR9 was
essential for p38 activation and dampened Akt phosphorylation in CLP mice. TLR9 deficiency
could revert splenic apoptosis and the increased levels of inflammatory cytokines 41. These
results suggested TLR9 and β-arrestin2 had common downstream effectors. The underlining
mechanisms might overlap in some key regulatory points (p38, GSK3β) but also could differ
from one disease model to another.
In the septic heart, the function of β-arrestin2 may mediate mainly by p38 through IL-6
pathway within 6 hours, but in ischemic heart, the loop regulation between β-arrestin2 and miR155 seems to be more important since cardiomyocyte regeneration/differentiation is critical for
more than two weeks of recovery from damage. Restrain chronically induced stress, is in a twoday pattern, TLR9 is an essential factor for restrained stress induced macrophage response and
apoptosis.
In a systemic model of sepsis, the understanding of disease pathogenesis should not be
confined to a single system. Different response mechanisms from non-immune system especially
the cardiovascular system should also be emphasized. Likewise, in a systemic model of βarrestin2 knockout and overexpression, the protective effect against systemic inflammation
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should also be evaluated in both immune system and non-immune system. To investigate the role
of β-arrestin2 on blood return, we measured cardiac function 6 h after sepsis; the result turned
out to have significant higher cardiac preload in β-arrestin2 TG mice, comparing to β-arrestin2
KO mice and WT mice. Therefore, the main contributor for the protective role of β-arrestin2
should be the preserved vascular integrity given the inflammatory nature of this model and its
influence on other organs with oxygen and nutrient deprivation.
Previous studies have established the GPCR desensitization and internalization role of βarrestin2 as well as β-arrestin 1, which theoretically would affect the signaling transduction of
various endogenous vasoactive substances during systemic inflammation and subsequently
vascular leakage and sympathetic response. In this study, β-arrestin1 expression seemed higher
in β-arrestin2 KO mice, suggesting complementary overexpression. Although the functional
redundancy has been indicated, the impaired cardiovascular function of β-arrestin2 KO mice
suggested the deficiency of β-arrestin2 can not be adequately compensated by β-arrestin 1 in this
acute severe sepsis model.
The loop regulation of β-arrestin2 and miR-155 was unexpected because in our hypothesis
β-arrestin2 was the target of miR-155. However, this result demonstrated a new way to
understand the function of miRNAs. We suspected miRNAs could be regulated by its goal
according to defined pathophysiological conditions, as in ischemia /reperfusion injury in this
study. This kind of exquisite regulation is protective for the injured organ tissue, promote
survival rate.
Our results showed TLR-9 was required for inflammation in chronic stress. The immune
suppression was prevented in TLR-9 knockout mice. The function of TLR-9 here is opposite to
β-arrestin2, which has been shown to be a negative regulator in multiple inflammatory diseases.
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The relationship between β-arrestin2 and TLR-9 can be predicated as β-arrestin2 could be an
inhibitor of TLR-9 in inflammatory disease. However, further studies should be performed to
verify this hypothesis.
In summary, β-arrestin2 is a potent cardiovascular protector and hemodynamic stabilizer in
CLP-induced polymicrobial sepsis. β-arrestin2 could rescue heart from myocardial infarction by
enhancing cardiac stem cell differentiation. TLR-9 as a potential target of β-arrestin2 is required
in chronic stress induced macrophage response. The study of β-arrestin2 regulated immune
response is crucial for developing new treatment and improving the prognosis of inflammatory
diseases.
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